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Abstract  
Over the past decade, advances in genetics have led to identification of thousands of genetic 
loci in the human genome that contribute to complex traits such as the timing of pubertal 
onset. Following genome-wide association studies (GWAS), we currently know how a large 
proportion of the heritability of complex traits can be explained by common genetic variation 
in these loci. However, in many instances, we understand relatively little about the biology 
behind these genetic associations, and functional characterization of genetic variation has 
become a new bottleneck for genetic research. This thesis project was essentially motivated 
by the need to move beyond the GWAS associations. Prior to the project, sequence variants 
nearby lin-28 homolog B (LIN28B) had become associated with pubertal timing in the general 
population. Remarkably, compared to all other common genetic variants, the variants in the 
LIN28B locus appeared to exert relatively large effects on pubertal timing: one pubertal 
timing advancing allele associating with ~1,5 months advancement in age at menarche 
(AAM) in females. Yet , the gene, encoding for an RNA binding protein regulating cell division 
by binding let-7 micro RNAs, showed little evidence of affecting the established mechanisms 
behind pubertal onset. Therefore, after our research group had been involved in establishing 
LIN28B as a pubertal timing gene, exploring the molecular mechanisms by which LIN28B 
affects puberty then became the focus of my thesis.  
This thesis is founded on three original studies that have sought to elucidate LIN28B function 
from different perspectives. The first study utilized Finnish population cohorts to assess the 
potential pleiotropy of the gene in terms of body size and adult health. The second study 
combined human gene expression data from the GTEx database with zebrafish models, 
evaluating the consequences of transient dysregulation of lin28b during embryogenesis. For 
the third study, we first created lin28b knockout zebrafish with CRISPR-Cas9 technology to 
evaluate the effects of permanent lin28b knockout, and utilized the GTEx data and the UK 
biobank resource to study whether LIN28B contributes to sex steroid signaling in humans. 
Whereas the first study aimed to get an overview of the effects LIN28B has on human 
anthropometry and health, the second and the third were specifically aimed to elucidate the 
molecular mechanisms by which LIN28B affects traits like pubertal timing. In particular, this 
thesis project has focused on studying how LIN28B contributes to vertebrate development, 
and affects the function of the hypothalamic-pituitary (HP) axis. 
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The results presented in this thesis suggest that LIN28B has pleiotropic actions on vertebrate 
phenotypes and may contribute for example to the regulation of human body size in more 
complex ways than originally thought. Our studies demonstrate how the gene associates 
with variation in several body size parameters including hip size in humans, although 
showing little evidence of affecting metabolism in adults. The results also suggest that the 
effects that LIN28B has on body size are evolutionarily conserved. Based on models including 
transient manipulation of lin28b in zebrafish embryos, overexpression of the gene during 
embryogenesis appears to stimulate zebrafish growth, and intriguingly lin28b knockout 
zebrafish show similar growth patterns as humans that carry sequence variants linked with 
lower LIN28B expression. Importantly, the data presented in this thesis indicates that the 
sequence variants associating with pubertal timing affect LIN28B expression mostly in the 
hypothalamus and the pituitary of adult humans. It appears that this may have functional 
consequences: LIN28B expression at the HP axis seems to correlate positively with the 
expression of several hormonal genes like ESR1 and POMC. Highlighting the gene’s potential 
to contribute to sex steroid signaling, we finally associate LIN28B with regulation of 
testosterone levels in adult humans, which might be relevant in terms of explaining many of 
the GWAS associations. Overall, the original studies on which this thesis is based on have 
offered novel insight into LIN28B function in pubertal timing, heath and disease, enforcing 
the concept of the gene as a fundamental player in vertebrate growth and development. 
Besides helping to elucidate the function of LIN28B, the project has simultaneously served 
as an example for follow-up studies of GWAS loci in general. 
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Tiivistelmä 
Edistysaskeleet genetiikan tutkimuksessa viimeisen kymmen vuoden aikana ovat johtaneet 
satojen sellaisten perimän kohtien tunnistamiseen, joissa esiintyvä vaihtelu vaikuttaa 
monitekijäisiin tauteihin ja ominaisuuksiin. Genominlaajuisten assosiaatiotutkimusten 
(GWAS) ansiosta tiedämme nykyisin kuinka merkittävä osuus monitekijäisten 
ominaisuuksien periytyvyydestä selittyy näiden kohtien yhteisvaikutuksella. Biologia näiden 
geneettisten assosiaatioiden taustalla on kuitenkin valtaosin huonosti ymmärrettyä. 
Tarpeesta ymmärtää miten nämä perimän kohdat vaikuttavat eri ominaisuuksiin ja tauteihin 
onkin muodostunut uusi pullonkaula geneettiselle tutkimukselle. Tämä väitöskirja sai 
alkunsa halusta ymmärtää murrosikään liittyvien GWAS-löydösten taustaa. Hieman ennen 
väitöskirjaprojektin alkua, ryhmämme oli ollut mukana liittämässä perimän vaihtelua 
LIN28B-geenin alueella murrosiän ajoittumiseen. LIN28B valikoitui tämän tutkimuksen 
kohteeksi erityisesti kahdesta syystä. Ensiksi, geenin lähellä sijaitseva geneettinen vaihtelu 
näyttää vaikuttavan murrosiän ajoittumiseen enemmän kuin mikään toinen yleisesti jaettu 
muutos genomissa: esimerkiksi naisilla yksi puberteettia varhaistava alleeli assosioituu n. 1,5 
kuukautta varhaisempaan kuukautisten alkamiseen. Toiseksi, geeni ei kuitenkaan näyttänyt 
kytkeytyvän niihin mekanismeihin, joiden on aikaisemmin osoitettu vaikuttavan murrosiän 
alkamisen taustalla: LIN28B:n tiedettiin lähinnä kontrolloivan let-7 mikroRNA-molekyylien 
biogeneesiä joka puolestaan oli liitetty solujen jakautumiseen ja erilaistumiseen.  
Väitöstyössäni keskityinkin selvittämään sitä, miten LIN28B voisi vaikuttaa murrosiän 
ajoittumiseen. 
Tämä väitöskirja perustuu kolmeen osatyöhön, joissa on pyritty selvittämään LIN28B 
toimintaa eri näkökulmista. Ensimmäisessä tutkimuksessa hyödynsimme suomalaisia 
väestöaineistoja FINRISKI-tutkimuksista selvittääksemme voisiko geeni liittyä laajemminkin 
kehon koon säätelyyn ja aikuisterveyteen. Toisessa osatyössä yhdistimme 
geeniekspressiodataa GTEx tietokannasta seeprakalamallien kanssa, tutkiaksemme muun 
muassa miten GWAS tutkimuksissa löydetyt geenivariantit vaikuttivat LIN28B:n 
ilmentymiseen, ja kuinka sikiöaikainen muuntelu lin28b:n ekspressiomäärässä vaikuttaa 
kehitykseen. Kolmannessa osatyössä jatkoimme GTEx datan analyysiä ja loimme 
poistogeenisiä lin28b-seeprakalamalleja tutkiaksemme pysyvän lin28b:n hiljentämisen 
  
12 
 
vaikutuksia. Siinä missä ensimmäinen työ tarjosi yleiskatsauksen siihen kuinka LIN28B 
vaikuttaa kehon kokoon ja terveyteen liittyvään aineenvaihduntaan, toinen ja kolmas oli 
suunnattu erityisesti niiden molekyylitason mekanismien tutkimiseen joilla LIN28B voisi 
vaikuttaa esim. murrosiän ajoittumiseen. Näissä tutkimuksissa erityisenä kiinnostuksen 
kohteena olivat LIN28B:n mahdolliset vaikutukset hypotalamuksen ja aivolisäkkeen 
toimintaan.  
Tässä väitöskirjassa esitetyt tulokset osoittavat LIN28B:n vaikuttavan selkärankaisten 
kasvuun ja kehitykseen monin eri tavoin: esimerkiksi ihmisen kehon koon muotoutumiseen 
monimutkaisemmilla tavoilla kuin aikaisemmin oli tunnettu. Kuitenkin, tutkimusten 
perusteella voitiin todeta, että geeni ei todennäköisesti vaikuta aineenvaihduntaan 
merkitsevästi aikuisväestössä. Väitöskirjassa esitetyt tulokset tukevat käsitystä LIN28B 
evoluutiossa säilyneestä roolista selkärankaisten kasvun säätelyssä. Hetkellinen lin28B:n 
yliekpressio seeprakalan alkioissa näyttäisi stimuloivan kalojen kasvua, siinä missä pysyvä 
lin28b:n hiljentäminen johtaa samanlaisiin muutoksiin kasvussa kuin ihmisillä joilla on 
matalampaan LIN28B ekspressiotasoon liittyvä muoto geenistä. Tutkimuksemme osoittavat 
lisäksi kuinka sama perimän vaihtelu joka liittyy murrosiän ajoittumiseen LIN28B geenin 
lähellä, vaikuttaa LIN28B:n ilmentymiseen erityisesti etenkin murrosiän kannalta tärkeissä 
kudoksissa, hypotalamuksessa ja aivolisäkkeessä. Tällä on mahdollisesti myös toiminnallisia 
seurauksia: LIN28B ilmentyminen näyttäisi korreloivan useiden hormonaalisten geenien 
ilmentymisen kanssa hypotalamuksessa ja aivolisäkkeessä. Korostaen geenin mahdollista 
roolia sukupuolihormoneihin liittyvään signalointiin liittyen, väitöstutkimukseni nostaa esiin 
erityisesti ESR1- ja POMC-geenit, sekä linkittää LIN28B:n testosteronitasojen säätelyyn 
aikuisilla, joka voisi selittää osan LIN28B:hen liitetyistä fenotyypeistä. Kaiken kaikkiaan, 
tutkimusprojektit jotka nyt esitellään kootusti tässä väitöskirjassa ovat siis tuoneet lisätietoa 
siihen miten LIN28B vaikuttaa murrosikään, terveyteen ja yksilönkehitykseen, vahvistaen 
käsitystä geenistä merkittävänä tekijänä selkärankaisten kasvun säätelyssä. Paitsi että 
väitöstutkimukseni on tuonut uutta tietoa niihin molekyylitason mekanismeihin joilla LIN28B 
mahdollisesti vaikuttaa kasvuun ja kehitykseen, projektimme toimii myös yleisellä tasolla 
esimerkkinä keinoista joilla voidaan lähteä tutkimaan GWAS-löydösten biologista taustaa.  
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Introduction: Pubertal timing, a crucial event in development - 
LIN28B, a crucial gene for pubertal timing 
The onset of puberty is a crucial milestone in development, marking the beginning of sexual 
maturation, the key developmental stage between childhood and adulthood. As a 
developmental event, the onset of puberty is distinctive in nature, having dramatic 
consequences for both the appearance and behavior in all vertebrates. Nonetheless, instead 
of being an isolated event in life, pubertal onset can be perceived as a culmination point of 
all the prior development that has taken place to ensure sexual maturation can proceed. This 
development begins at the time of conception, terminating at the second decade of human 
life. On average, the timing of pubertal onset in humans varies substantially between 
individuals, sexes and populations, usually occurring between the ages of 8 and 14 in modern 
societies (1-3). Importantly, this essential milestone in human development, having strong 
genetic basis, is known to correlate with several body size parameters and risk for many 
diseases (4-6).  
 
Despite the evidence that heritability of pubertal timing is relatively high (50-80%) and 
although several monogenic syndromes affecting pubertal development had been identified, 
relatively little was known about the contribution of individual genes to pubertal timing in 
the healthy population when the work for this thesis begun in 2011 (6-8). At the same time, 
technological and analytical advances had made it possible to conduct large-scale genome-
wide association studies (GWAS) to elucidate the genetic background of puberty. Our 
research group had been involved in identifying LIN28B – the gene under the focus of this 
thesis - as one of the first genetic loci where common genetic variation could be linked with 
changes in pubertal timing and growth in the healthy population (9). In fact, the variants 
nearby LIN28B still appear to have the biggest effects on pubertal timing out of all examined 
common variants (10). Prior to GWAS, studies in the nematode C. elegans had already 
indicated that LIN28-genes might have potential to affect developmental timing (11). 
However, at the time of the initial discovery in humans, LIN28B showed no direct biological 
links to the established physiological mechanisms that regulate pubertal onset. Since then 
several GWAS, nowadays encompassing massive number of subjects, have identified 
hundreds of more loci contributing to pubertal timing in the general population (10, 12, 13). 
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Meanwhile, the LIN28B association with pubertal timing has remained robust, whilst the 
gene has become associated also with many other traits, ranging from depression and 
intraocular pressure to bone mineral density (BMD) and height (14-18). Yet, the mechanisms 
by which the gene affects all these phenotypes have remained somewhat elusive. 
 
Essentially, the gap in the knowledge linking LIN28B with puberty provided the ultimate 
motivation for this thesis. In a wider context, the case of LIN28B and puberty however is not 
an unusual case:  in the wake of the GWAS era, the bottleneck for genetic research is not 
anymore “finding the right gene” as it was in the past. Currently, larger and larger studies 
like the UK biobank study (UKBB) and the FinnGen project (www.finngen.fi/) have yielded, 
and will yield a huge number of replicable genetic associations with a vast number of traits 
(19). Instead, to find out the biological mechanisms by which the identified genetic loci 
contribute to various phenotypes remains as a big challenge (20). Providing an example of a 
project that aims to take the leap from the associations into understanding the underlying 
biology, this thesis has concentrated on unraveling the mechanisms behind the LIN28B 
associations with growth and pubertal timing. In the studies forming the body of this thesis, 
we have used several different approaches to “move beyond the GWAS results”. To study 
LIN28B function, we have utilized data from Finnish population cohorts and international 
gene expression databases, and combined these with our own in-house animal models that 
reveal interesting aspects about the physiology of pubertal timing and the function of 
LIN28B.  
 
The next chapters of this thesis aim to introduce the known physiology and hormonal 
mechanisms behind pubertal timing, with a special focus on the development of the 
hypothalamic-pituitary-gonadal (HPG) axis. Following description of what is currently known 
about the function of LIN28B, the literature review concentrates on the remaining question 
of how to move forward from the genetic associations into understanding the biology: the 
required step to fully translate the value of the scientifically solid genetic associations. After 
the literature review, results from the three original studies serving as the basis of this thesis 
are recapped and discussed. The final chapter then aims to summarize what we have learned 
about the mechanisms linking LIN28B with pubertal timing, and what we have learned about 
studying GWAS loci in general.
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2. Literature review 
2.1 The physiology of pubertal onset and epidemiology of pubertal 
timing 
 
2.1.1 Setting the stage: embryogenesis and childhood development 
 
In humans, the physical development from child to adult is a continuous process that takes 
almost two decades, culminating at pubertal period that marks the transition from childhood 
into sexual maturity. Traditionally, sexual maturation - the attainment of reproductive 
capability - has been considered as the final physical step between childhood and adulthood, 
although the development of the human brain and secondary sexual characteristics may 
continue for several years beyond this point (21). Importantly, past research has shown that 
the onset of puberty marks a huge shift in the secretion of sex steroids (androgens, estrogens 
and progestogens), causing the physiological changes associated with puberty (22, 23). The 
central event triggering the sex steroid secretion is the establishment of pulsatile release of 
gonadotropin-releasing hormone (GnRH) from the hypothalamus. This event is currently 
relatively well characterized, and many factors that affect GnRH secretion have been 
identified, including neuropeptides kisspeptin and dynorphin, and balance of glutamatergic 
vs. GABAergic stimulation of the GnRH neurons (24, 25). However, the physiological and 
environmental mechanisms that precede, and ultimately trigger the GnRH secretion and 
pubertal development remain poorly understood (24, 25).  
 
Although the onset of puberty appears to be a distinctive event in human development, it 
can be seen as the final event in childhood growth that in turn has foundations in fetal 
growth, beginning upon fertilization. In fact, the tissues responsible for pubertal onset, 
forming the hypothalamic-pituitary-gonadal (HPG) axis, develop already during 
embryogenesis (26-28). The HPG axis consists of specific neurons and glands, including the 
hypothalamic GnRH neurons and the glands secreting the pituitary gonadotrophins 
(lutenizing hormone (LH) and follicle-stimulating hormone (FSH)) that stimulate sex hormone 
release from the gonads. Remarkably, once formed, the HPG axis shows transient activation 
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already before puberty, but becomes permanently activated only when the pubertal 
development begins (26-28). Studies on human fetuses have shown that HPG activity is first 
detected during midgestation (26-28). Towards the end of pregnancy, this activity declines, 
but is again transiently restored after birth (26-28). The biological significance of these 
periods of HPG activity before puberty is not completely understood, but it appears 
necessary for example for the development of the male genitalia, and likely induces changes 
also in the organization of neural networks that contribute to sex-specific behavior (26-28). 
Supporting the concept that the HPG axis forms early and is thereafter potent to induce 
gonadotrophin secretion upon suitable stimuli, animal experiments have shown that the axis 
can be permanently activated already during childhood. For example, in rhesus monkeys, 
spermatogenesis and ovulation can be induced prematurely by hormonal treatment (25).  
Interestingly, animal experiments and clinical observations in humans tell also the 
complementary story: various conditions causing low gonadotrophin levels, reflecting the 
malfunction of the HPG axis, can lead to delayed or absent puberty (25). In some cases these 
conditions are known to be caused by defects in fetal development. For example, the GnRH 
neurons are not hypothalamic in origin, but rather migrate to the hypothalamus from the 
olfactory placode during embryogenesis (29, 30). Failures in this migration, leading to 
Kallman syndrome, have been associated with problems in later pubertal development (31, 
32).  In the light of the current research, although the exact molecular mechanisms triggering 
pubertal onset are incompletely understood, puberty can anyhow be viewed as a unique 
event in human growth that is ultimately based on successful embryonic and childhood 
development. 
 
2.1.2 The mechanisms of pubertal onset 
 
The studies on the mechanisms responsible for pubertal onset truly took off at the second 
half of the 20th century, a couple of decades after sex hormones had been identified and 
isolated (25, 33, 34). The hypothesis that a specific neural stimulus that triggers pituitary 
gonadotrophin release activates pubertal development was finally confirmed when two 
independent research groups isolated GnRH, a hypothalamic decapeptide in 1971 (25, 35, 
36). Since then, a lot of research has been concentrated on understanding the molecular 
mechanisms that are responsible for the pulsatile GnRH release associated with pubertal 
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onset. Naturally, both the development and function of the GnRH neurons has been studied 
extensively. However, the formation of the HPG axis is not limiting for pubertal onset, as the 
axis is ready to function already during the fetal stages, a lot of emphasis has been put on 
studying which factors are responsible for re-activating the system after the quiescent 
childhood period (24, 25, 37). The current theory holds that puberty begins when multiple 
different genetic and environmental signals converge and signal the brain to activate the 
HPG axis (Figure 1) (24, 25, 37, 38). The hallmark of this activation is the re-activation of the 
pulsatile GnRH release from the hypothalamus, causing gonadotrophin secretion from the 
pituitary. The theory predicts that there exists a type of neurobiological brake that has been 
on since late infancy, but is switched off to launch pubertal development in humans. This 
brake has been conceptualized to consist of several neurotransmitters, neuropeptides and 
environmental signals. Whether the brake is simply related to the somatic development, or 
is regulated by a clock-like mechanism in the brain has not been properly addressed (24, 25, 
38). Similarly, the mechanisms that switch on the brake in the childhood remain unknown. 
Nonetheless, all research done over the past decades points towards the concept that there 
is no single biological signal or a gene that is responsible for pubertal onset: rather, we now 
known that there exists many “permissive” factors that seem to affect the initiation of 
pubertal development (38).  
At present, it is thus widely accepted that integration of several neuronal signals to stimulate 
the pulsatile GnRH release upon puberty is required. In simple terms, this pulsatile GnRH 
release activity depends on the balance of excitatory and inhibitory inputs that originate 
either from hypothalamic neurons or glial cells (24, 25, 38). Recent genetic studies have 
identified several genes that seem to act as upstream regulators of the GnRH secretion. For 
example, genetic studies on hypogonadotrophic hypogonadism (HH), a syndrome leading to 
absent puberty, have highlighted the importance of kisspeptin (KISS1), neurokinin B and their 
receptors (KISS1R and TAC3R, respectively) for proper GnRH secretion (39-41). 
Correspondingly, functional studies have shown that both KISS1 and neurokinin B can 
stimulate GnRH release (24, 42, 43). Although these genes indeed participate to the cascade 
that triggers the GnRH release, it is worth noting that they do not directly “regulate” pubertal 
timing. Rather, these genes can be viewed as downstream players that are activated after 
the neurobiological brake has been switched off.  
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Figure 1.    A schematic model of the function of the 
hypothalamic-pituitary-gonadal (HPG) axis that 
controls gonadotrophin-releasing hormone (GnRH) 
pulse generation triggering puberty.   To launch 
puberty, poorly understood neural mechanisms 
activate Kisspeptin (KISS1) neurokinin B (NKB) and 
glutamatergic (GLU) neurons, leading to stimulation 
of GnRH pulse generation and GnRH release from 
the hypothalamus. Glial cells are also known to 
stimulate GnRH release. GABAergic neurons (GABA= 
γ-aminobutyric acid) and dynorphin (DYN) 
expression from the arcuate nucleus have been 
suggested to be part of a prepubertal brake on 
GNRH secretion. Ultimately, the pulsatile GnRH 
release leads to secretion of LH and FSH, which then 
stimulate gonads to secrete sex steroids. The sex 
steroids testosterone and estrogen are responsible 
for example of the growth spurt associated with 
pubertal timing, and the development of the 
secondary sexual characteristics. Figure based on 
Sisk and Foster 2004 & Herbison 2016(24, 38).
In combination with the genetic studies, physiological and “omics” studies have been 
successful in identifying molecular mechanisms and factors that are crucial for the regulation 
of the pubertal onset. Studies on the role of neurotransmitters in the regulation of puberty 
have linked changes in the γ-aminobutyric acid (GABA) and glutamate signaling with pubertal 
onset (44, 45). Notably, pubertal onset has been correlated with a decrease in GABA, the 
major inhibitory neurotransmitter in monkey brain, but whether GABA contributes directly 
to GnRH regulation remains poorly understood. Contrastingly, GnRH release can be 
stimulated in monkeys by glutamate analog N-methyl-D-aspartate (NMDA) (46). Other 
peptides and mechanisms related to pubertal timing include dynorphin, an opioid peptide 
which has been associated with inhibition of GnRH secretion (47). Lately, also a role for 
hypothalamic glial cells in stimulating pubertal onset has been proposed (37).  Nevertheless, 
the same limitation applies to these findings as in the case of KISS1 and neurokinin B: 
although changes in the content of these neurotransmitters in critical regions of the brain 
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would somehow be related to triggering puberty, the ultimate cause for these changes 
remains unknown.  
 
2.1.3 Pubertal timing , a complex trait showing normal distribution 
and sex differences in the general population 
 
Although the basic physiological mechanisms that lead to pubertal onset have been 
characterized, the factors that affect the timing of puberty are less well understood. In 
epidemiological terms, pubertal timing represents a complex trait that varies roughly 
according to the normal distribution in the general population. Like other complex traits, 
pubertal timing is thought to be determined by the interaction of multiple genetic and 
environmental factors, which will be discussed in more detail in the following sections of this 
literature review.  As a result of these factors, the timing of pubertal onset may vary 
considerably between given two individuals, although for most people the pubertal onset 
still occurs close to the population mean. 
 
Like most physiological traits, pubertal timing as well as pubertal tempo (how fast the 
puberty proceeds) differs between sexes in humans. On average, girls start to show the first 
signs of pubertal development between 8 and 13 yrs of age, whereas the earliest 
manifestations of puberty can be usually seen in boys between the ages 9 and 14 (1-3). 
Figure 2 shows illustration of the timing of pubertal development for both sexes.  The fact 
that girls enter puberty earlier than boys is well established, but the reasons for this 
phenomenon remain somewhat unclear.  Interestingly, it has been shown that girls tend to 
optimize brain connections earlier than boys (48). Therefore, it can be speculated that the 
sex differences in pubertal timing might be directly related to the maturation of the neural 
networks and hormonal mechanisms that ultimately control pubertal onset. Compared to 
most animals, humans exhibit relatively late onset of puberty. This type of sex difference in 
the maturation rate is still not specific to humans: for example in savanna baboons and 
several other animals males usually mature later than females (49). Notably, examples of the 
opposite pattern in other species also exist: for example male salmons tend to mature earlier 
and at smaller size than females (50).  
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Figure 2. Schematic representation of timing of pubertal development in boys and girls. Panels A and 
B show mean growth in cm/year and rough age for peak height velocity, spermarche, menarche and 
Tanner stages for boys and girls. Panel C shows visualization of Tanner stages.  Adapted and based on 
images from Physiologic Growth and Development During Adolescence David S. Rosen (2004) and 
Michal Kormorniczak (shared under creative commons license)(51). 
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  2.1.4 Pubertal timing and links to body size  
 
As a physiological phenomenon, pubertal timing is closely intertwined with the development 
of several anthropometric traits, and some well-known, though complex correlations 
between pubertal timing and body size in humans exist. Perhaps the most studied 
correlations exist between pubertal onset and obesity. In girls, earlier sexual maturation has 
been associated with higher body mass index (BMI), whereas physical activity and resulting 
lower body fat correspondingly associate with later pubertal onset (52-55). The observation 
that increased BMI in childhood leads to earlier pubertal onset in girls is likely related to the 
hypothesis that before entering puberty the brain needs to get signals from the body that 
enough growth has occurred to support the potential consequences of the sexual 
maturation, namely raising the offspring (52).  Contrastingly, in boys higher BMI does not 
seem to advance pubertal maturation: in some studies obesity in boys has even been 
associated with delayed puberty (56). Noteworthy, however, the relationship between 
puberty and obesity in boys has been less studied compared to girls.  
 
Whereas obesity may directly modulate pubertal timing, the links between puberty and 
height may be more complex, though especially the former is known to affect the latter. In 
girls, earlier pubertal onset seems to associate with shorter adult height, potentially due to 
subsequent earlier cessation of growth (57, 58). In boys, the results are again somewhat 
different: studies have suggested that earlier pubertal maturation may correlate even with 
slower pubertal progression and taller stature as adults, though this remains under debate 
(6, 57). Highlighting the complexity of growth and the interplay between height, obesity and 
puberty, increased height seems to correlate with childhood obesity, but this correlation 
disappears in adults (59, 60).  It is generally accepted that part of these correlations might 
be explained by the actions of various hormones including growth hormone (GH), leptin and 
the sex hormones, but overall the developmental mechanisms contributing to body size and 
pubertal onset seem to be complex. 
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2.1.5 Disturbances in pubertal timing 
 
Based on the normal distribution, for most people the pubertal onset occurs +1 yrs from the 
population mean. Yet, pubertal onset that falls at the extreme tails of the normal distribution 
might be indicative of a medical condition (1, 3). Traditionally, three classes of pubertal 
timing disorders are recognized. Pubertal timing can happen either exceptionally early 
(precocious puberty) or late (delayed puberty), and in rare cases, the initiation of puberty 
might be completely stalled (absent puberty). Due to undefined reasons, it appears that girls 
are more likely to suffer from precocious puberty, whereas boys are more likely to show 
delays in puberty(61). Conventionally, the limits for abnormally precocious sexual 
maturation have been set as puberty initiation of less than 8 yrs for girls and 9 yrs for boys 
(1, 3, 61). On the other hand, puberty is considered to be delayed if a person does not show 
any apparent signs of pubertal development by the age of 13 (girls), or 14 (boys) (1-3).  
Notably, these limits are largely based on epidemiological studies made in the UK several 
decades ago, and thus not might directly apply to every modern population (62, 63).  
 
  2.1.6 Heritability of pubertal timing 
 
Although the onset of puberty may vary extensively between individuals, generally the 
timing of puberty appears highly heritable. It has been estimated that ~50-80% of the 
variation in pubertal timing is affected by genetic factors in western societies (3, 6, 64). The 
evidence for such a high genetic contribution comes from the combination of many sources. 
For example, the average timing of pubertal onset is known to vary from population to 
population, and even within a population based on ethnic group (1, 64, 65). It is also known 
to show a high correlation between family members, and twin studies have indicated that 
pubertal timing varies less between monozygotic than dizygotic twins (66). The data 
estimating the heritability of pubertal timing is largely based on studying the age at 
menarche (AAM), but interestingly the analyses of other proxies of pubertal development 
such as the height growth spurt have estimated the genetic contribution to be even higher 
(>90%) (6). Like in the case of some other physical traits (e.g height), the estimated relatively 
high heritability might be a reflection of the fact that environmental influences such as 
disease and undernutrition contribute relatively little to pubertal timing in modern societies.  
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  2.1.7 Environmental influences on pubertal timing 
 
Despite the apparently high heritability of pubertal timing, environmental factors may still 
have a major influence on the onset of puberty, both at the population and individual level. 
For example the age references for normal pubertal timing still vary between well-off and 
underprivileged countries, largely due to environmental factors, including diet (1). On the 
other hand, the timing of puberty has changed in the western world over the past century. 
In many countries, a secular trend in pubertal timing has been evident, meaning that the 
average age when pubertal maturation starts has continue to decline. For example in 
Finland, the average AAM used to be >17yrs in the middle of the 19th century (67), whilst by 
1969 it had come down to 13.3yrs (68), being around 13.3 yrs still in 1993(1). Similarly, in the 
USA the average AAM has fallen from 13.5 yrs to 12.3 yrs when comparing females born in 
1908-9 to those born between the years 1990-93 (69).  
 
The potential reasons behind these secular trends may vary. Yet, since the genetics of a given 
population are unlikely to change as rapidly as the average AAM has fallen, these are likely 
related to environmental changes. One of the key environmental contributions to growth is 
nutrition. Data from several sources indicates that maturation is largely dependent on 
nutritional conditions in many species ranging from invertebrates to humans (1, 49). In 
simple terms, this means that for puberty to begin, a critical amount of growth has to occur. 
For example zebrafish do no become sexually mature before reaching a threshold weight, 
and some studies have estimated that normal menstrual cycling in females requires at least 
22% of body fat (1, 70). In many animals additional factors related to ecology and socio-
demography are key contributors to the timing of sexual maturation, partly through affecting 
nutrient availability between individuals. Also in humans, factors like stress, climatic 
conditions, and endocrine-disrupting chemicals have been speculated to contribute to the 
variation and secular trends in pubertal timing (1). 
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  2.1.8 Pubertal timing and health 
 
Pubertal timing and growth patterns during early life have been associated with many adult 
health related outcomes. Both early and late pubertal timing have been shown to correlate 
significantly with disease risk (4).  Particularly early pubertal timing has been robustly linked 
with all-cause mortality and the risk for several disease and traits relating to variable health 
conditions. These include for example cardiometabolic traits like higher adult BMI, fasting 
insulin, diastolic blood pressure, and decreased HDL cholesterol in both sexes, as well as 
disease like breast cancer and type 2 diabetes (4, 5, 71). As early onset of puberty has been 
shown to correlate with obesity, some of the associations might be directly related to BMI 
and adiposity. The role of obesity as a causal factor behind some of the associations has in 
fact been strengthened by many epidemiological and genetic studies, but pubertal onset 
seems to be also an independent risk factor for many diseases (4). A recent UKBB study 
including ~450,000 individuals showed how pubertal timing may directly affect the risk for 
several diseases, including some cancers, cardiovascular, musculoskeletal, gastrointestinal 
and neurological disorders in both sexes (4). A brief summary of these associations is 
presented in Table 1. Notably, both early (AAM between 9 and 11 yrs) and late (AAM 
between 15 and 17 yrs) puberty seem to affect adult health. Overall, the existing 
epidemiological associations between pubertal onset and health highlight the fact that 
ontogenesis and development of disease are closely related processes, and understanding 
the mechanisms that affect pubertal onset may have immediate medical relevance.  
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    2.2. The genetics of puberty 
 
2.2.1 The genetics of puberty – a complex affair 
 
Pubertal timing is a genetically complex, polygenic trait, whereas disorders causing either 
complete absence of puberty or severe cessation of pubertal development appear very rare 
in humans. For example the prevalence of HH, the most common collection of syndromes 
leading to absent puberty has been estimated to be around 1:10000-86000, including both 
congenital (genetic) and acquired cases in the US (72). Likewise, the prevalence of Kallman 
syndrome, a special form of HH is around 1:30000 in Finnish men, and 1:125000 in Finnish 
women (73).  
 
Although the genetic factors that explain most of the normal variation in pubertal timing in 
human populations are likely separate from those that underlie severe syndromes affecting 
the pubertal onset, these syndromes have anyhow offered critical insight in to 
understanding the basic mechanisms that trigger the puberty. The clinical spectrum of these 
syndromes varies to some extent. These may result from defects related to the function of 
the gonads, preventing normal sex hormone secretion (hypogonadism), or from lesions 
directly affecting the GnRH system, in which case the condition is a called 
hypogonadotrophic hypogonadism (HH). The inheritance patterns for genetic pubertal 
timing disorders also vary: they may result from dominant de novo – mutations, show X-
linked inheritance pattern, or be caused by recessive mutations that are often inherited in 
compound heterozygous form (8, 65). On top of the complex nature of pubertal genetics, 
epigenetic mechanisms have been shown to participate to regulation of the pubertal 
processes (74). 
 
Currently, the knowledge about the genes that contribute to pubertal timing has increased 
almost exponentially, and several excellent reviews about the current state of pubertal 
genetics have been written (65, 75, 76). The next chapters aim to provide a brief overview 
on the genetics of pubertal timing, concentrating first on established monogenic syndromes, 
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followed by an overview of the recent advances in understanding the polygenic contribution 
to puberty in the general population. 
 
2.2.2 Monogenic forms of pubertal timing disorders 
 
The studies on heritability of pubertal timing have shown that genes have considerable 
potential to affect the age at pubertal onset. Like for many diseases and traits, the first 
genetic insights onto the mechanisms that are responsible for the pubertal onset came from 
family studies which concentrated on identifying genetic lesions that interfere with pubertal 
progress.  These can be roughly divided into two categories: mutations that cause an early 
puberty, and mutations leading to pubertal progress being delayed or blocked. Several 
mutations that either advance or delay the onset of puberty have been currently identified. 
For example, mutations in more than 20 genes have been linked with syndromes that cause 
absent puberty (65, 75). Remarkably, emphasizing the pivotal mechanism behind pubertal 
onset, in most cases the mutations causing either precocious or absent puberty have been 
found to affect the hypothalamic GnRH release.  
 
Perhaps the best examples of the well-characterized monogenic syndromes related to 
pubertal timing are those causing an absent puberty. Especially studies on congenital HH and 
its distinctive form, the Kallman syndrome (collectively referred to as isolated GnRH 
deficiencies), have identified many key genes that contribute to pubertal onset. In general, 
the genes linked to absent puberty are immediately related to GnRH function. Usually, 
mutations in these genes prevent gonadotrophin secretion from the pituitary by interfering 
with the normal development of the GnRH neurons and hence GnRH release in the 
hypothalamus. The HH generally results from mutations in hypothalamic genes that 
participate to the GnRH release, whereas the Kallman syndrome, HH with anosmia (unability 
to smell) results from deficient GnRH neuron migration to the hypothalamus during 
embryogenesis. Mutations in several genes including ANO1 (KAL1), causing the Kallman 
syndrome, and for example FGF8, SOX10, GNRH1, GNRHR, and KISS1R have been linked with 
congenital HH (4, 65, 73). In addition to these HH cases, in rare cases mutations in the genes 
encoding for the pituitary hormones LH and FSH or their receptors have been identified as 
causes for absent puberty (77-79).  
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Compared to syndromes causing either severe delay or absence of puberty, the genetics of 
central precocious puberty (CPP) have been relatively less studied. The classification of 
precious puberty is somewhat arbitrary and has been traditionally defined as pubertal onset 
that occurs 2-2.5 SD before population mean (i.e. 8yrs in Caucasian girls and 9yrs in boys).  
Mutations in four genes, KISS1, KISS1R, makorin RING-finger protein 3 (MKRN3) and Delta-
like 1 homolog (DLK1) have been associated with this phenotype (80). Intriguingly, gain-of-
function mutations in KISS1 and KISS1R have been linked with CPP, as opposed to the loss-
of-function mutations in KISS1R causing absent puberty, consistent with the idea that 
kisspeptin release stimulates GnRH release and thus pubertal onset (39, 80-82). However, 
such mutations do not appear to be a common cause for CPP, likewise to DLK1 mutations. 
Instead, several studies have highlighted the contribution of MKNR3 to CPP (2, 80, 83). 
Contrasting the KISS1 findings, the normal function of both DLK1 and MKRN3 appears to be 
suppression of pubertal onset, as deletions in these genes have been associated with CPP 
(84). Both genes also show maternal imprinting, meaning that only the paternally inherited 
copy of the gene is expressed (84). Still, the exact mechanisms whereby the genes contribute 
to CPP remain unclear. 
 
2.2.3 Polygenic contribution to pubertal timing – insights from GWAS 
 
Besides the insights gained from monogenic disease, technological, methodological and 
analytical advances in the field of genetics over the past decade have made it possible to 
conduct large-scale association studies aiming to identify genes that contribute to the 
individual variation in pubertal timing in the healthy population. The genome-wide 
association studies (GWAS) have provided a successful hypothesis-free method to probe the 
pubertal genetics in an unbiased manner, leading to the identification of hundreds of genetic 
loci affecting pubertal timing in both sexes. As opposed to the findings from the monogenic 
disease (rare variants exerting large effects on pubertal timing in a core set of genes that are 
essential for puberty and usually show little variation in healthy individuals, discussed in 
chapter 2.2.2), the GWAS have instead pinpointed genes that contribute to the regulation of 
pubertal timing in more subtle ways. 
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Importantly, the GWAS have potential to tell us about the effects of common sequence 
variation, present in most of us, affecting “normal” population variation in many traits. The 
type of sequence variation the GWAS generally utilize is single nucleotide polymorphisms 
(SNP) that are used as markers for genomic loci. Traditionally, the GWAS have utilized dense 
SNP-based arrays to associate common sequence variation (previously defined as the marker 
locus having minor allele frequency (MAF) >5%, though modern studies have often set the 
limit to >1%) with a trait (85, 86). The GWAS can be divided into two categories depending 
on the experimental setup. Under a case-control setting, the GWAS aim to detect differences 
in the frequency of genetic variants between two groups (e.g. those who have a disease and 
those who do not + other dichotomous traits). Secondly, the GWAS can be applied to study 
quantitative traits in large population cohorts: in this case they compare whether the carriers 
of a certain genetic variant differ in a statistically significant way from the rest (e.g. are they 
on average taller than others). For dichotomous traits the statistical method used to detect 
association between a SNP and disease is usually logistic regression, whereas for quantitative 
traits linear regression is generally used. The results from the GWAS have been generally 
proven robust and replicable once common, stringent standards for these experiments took 
place (85, 86). These include for example the genome-wide significance threshold (P<5e-8), 
that is based on the assumption that a human genome contains roughly a million 
independent genetic variants (87).  
 
The era of GWASs began around 2005 when a study assessing age-related macular 
degeneration was published, reporting two single nucleotide polymorphisms (SNPs) that 
associated with the disease(88). It then took a few years before the first GWAS assessing 
pubertal timing were published in 2009 (89-92). These studies, consisting of 5000-25000 
individuals associated sequence variation near LIN28B with changes in the timing of AAM, 
which together with a locus at chromosome 9 became the first loci where common genetic 
variation could be linked with pubertal timing (Figure 3) (89-92). Since then, the number 
genetic loci shown to affect pubertal timing has grown to ~400, with the latest paper 
consisting of genetic data from ~370,000 women (10). By constantly increasing the sample 
size, the GWASs have become more powerful to detect common variants with minuscule 
genetic effects. Despite the associations have generally proved to be robust, the effects of 
most individual loci are relatively small, and at the moment they have been estimated to 
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explain collectively ~7.4% of population variance and ~25% of the heritability of AAM(10).  
Consistent with the epidemiological data, many of the pubertal timing loci affect also body 
mass, reflecting the close relationship between pubertal timing and body size (93).  
Moreover, the pubertal timing loci often contain genes whose function seems to be 
conserved in evolution: for example genes like LIN28B and VGLL3 have been shown to affect 
developmental timing and sexual maturation in species ranging from nematodes to fish, 
mice and humans (9,49). Though larger and larger GWASs will likely provide more hits in the 
future, the common variants that exert the biggest effects on pubertal timing have likely 
already been identified. Generally, the results from the GWAS emphasize pubertal timing as 
a complex trait. For example, although some of the hundreds of genes linked with the trait 
can be directly associated with GnRH-related pathways, most of the genes have been never 
linked with pubertal timing before the GWASs, stressing the important contribution these 
studies have made for understanding the genetics of pubertal timing.  
 
Regarding the interpretation of the GWAS results, some limitations still exist. Although 
strong, replicable statistical associations with several genetic loci and pubertal timing now 
exist, in most cases we still do not know the true causal variant, nor the causal gene behind 
the association signal. In the case of pubertal timing it also must be kept in mind that most 
studies have been targeting AAM, and the results from these studies should not be 
generalized directly to be applicable in both sexes. Yet, smaller studies using Tanner staging, 
age at voice brake and the timing of the pubertal growth spurt as proxies of pubertal timing 
have made it possible to study also pubertal timing in men (16, 94, 95). By and large, the 
results from these studies overlap, and many of the pubertal timing associated genes show 
association in both sexes (13). For example, several different SNPs in the LIN28B locus have 
been robustly associated with pubertal timing in both males and females.  
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Figure 3. Visualization of the association of LIN28B locus with age at menarche (AAM).  The upper panel shows a 
manhattan plot depicting chromosomal regions that show association with AAM in the UKBB cohort(19). The  region 
close to LIN28B contains several sequence variants that show robust association with AAM (Black box). Notably the 
locus contains the most significant AAM associations out of all tested genomic regions, as indicated by the log10 p-
value shown in the y axis. The lower panel shows a zoomed-in regional association plot of the LIN28B locus, showing 
the location of rs7759938, one of the markers associated with AAM, and rs314279, another marker studied in this 
thesis. The marker resides in a haplotype overlapping LIN28B anti-sense mRNA and LIN28B promoter region that 
seems to drive the association signal in the locus. Figure and data adapted from Oxford Brain Imaging Genetics (BIG) 
Server (v2.0, http://big.stats.ox.ac.uk/ ) 
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2.2.4. Epigenetic control of pubertal timing 
 
Epigenetics refers to heritable mechanisms that affect gene expression without causing 
direct changes to the DNA sequence. These mechanisms are mostly related to changes in the 
DNA methylation and chromatin structure, caused by cellular mechanisms involving 
methylation enzymes, histone modifications and miRNA activity (96, 97). Heritable in this 
context refers to both meiotic and mitotic inheritance, meaning that the epigenetic changes 
can either be inherited from a parent to child, or from a parent cell to the daughter cells. In 
terms of puberty, this means two things.  On one hand, some of the heritability in pubertal 
timing may be explained by meiotically inheritable epigenetic changes in the genome. On 
the other, epigenetic changes that are part of the normal ontogeny, occurring for example 
in the cells of the hypothalamus, may be crucial for the regulation of the pubertal onset.  
 
Parental origin effects, referring to whether a sequence variant is inherited from the father 
or the mother, represent a subclass of heritable epigenetic mechanisms (98). This is generally 
referred to as genomic imprinting. It is an epigenetic phenomenon which means that only 
either paternally or maternally inherited copy of a gene is expressed, whereas the other 
allele remains silent following DNA methylation. Interestingly, several genes linked to 
monogenic forms of pubertal timing disorders have been shown to be imprinted, including 
MKRN3 and DLK1 (83, 84). Also GWAS have associated several imprinted loci with pubertal 
timing. A larger proportion of sequence variants associated with AAM seem to reside in 
imprinted genomic locations compared to all other studied complex traits (4.8% vs. 1.7%) 
(13, 65). The observation that many pubertal timing genes might be imprinted may have 
evolutionary background. It has been speculated that imprinting has emerged as a means to 
address the parental conflict of resource allocation. Maternally expressed genes should favor 
earlier puberty (to ease the parental load of mothers), whereas the normal function of 
paternally expressed genes should be to delay puberty (demanding more resources from the 
mother), like in the case of MKRN3 and DLK1 (83, 84). The gene that is the focus of this thesis, 
LIN28B, has not been shown to be imprinted in adult human tissues, but there is some 
evidence that it may be imprinted in the placenta, where the paternal allele is preferably 
expressed (99).   
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Besides some of the pubertal timing genes showing heritable imprinting, epigenetic changes 
at the time of pubertal onset in relevant tissues may be vital for understanding the molecular 
mechanisms that cause puberty. Pubertal timing involves a dramatic shift in the gene 
expression at the HPG axis, and such substantial changes in gene expression are thought to 
be driven largely by epigenetic mechanisms (100). In fact, epigenetic changes involving 
chromatin remodeling in the hypothalamus at the time of puberty have been shown to be 
extensive, causing either up- or downregulation of selected genes (37, 101, 102). For 
example, it has been shown that in rats changes in the methylation of the Kiss1 promoter 
region, leading to activation of Kiss1 expression, occur around the time of puberty (101). 
Despite these examples and the appealing concept that epigenetic regulation must 
contribute to pubertal onset, the research over this subject is still in its infancy and we are 
only beginning to understand the nature and causes behind the epigenetic mechanisms that 
affect puberty. 
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2.3 LIN28B, a special pubertal timing gene 
   
2.3.1 Discovery of LIN28B, an evolutionarily conserved regulator of 
development timing  
 
The studies that form the body of this thesis have been largely concentrated on 
understanding the function of LIN28B, a gene associated with pubertal timing via GWAS in 
humans. The next sections of the literature review will concentrate on describing the 
discovery, known function and some open questions related to LIN28B and its role in human 
development. Before the work for this thesis begun, relatively little was known about the 
normal function of LIN28B. In fact, the gene was identified in humans only few years before 
the GWAS discoveries. In 2006, a Japanese group reported cloning and characterization of a 
novel gene lin28-homolog B (LIN28B) that was overexpressed in hepatocellular carcinoma 
(103). However, already by the end of the decade, homologous genes LIN28B and LIN28A 
were under intensive study, after discoveries from various fields had linked the LIN28 genes 
with cancer, growth and stem cell biology. Similarly to other genes in the LIN28 family, 
LIN28B encodes for a RNA-binding protein containing a cold shock domain (CSD) and two 
retroviral-type (CCHC) zinc finger motifs (Figure 4) (103, 104). LIN28 genes are found in all 
metazoans, and the essential domains of the proteins are highly conserved in evolution.  No 
other proteins are known to contain such a combination of functional domains, suggesting 
the LIN28 genes may have a special role in the biology of animals (103). The genes are highly 
expressed during embryogenesis in all studied animal species, ranging from nematodes and 
fruit flies to chicken and mice, and are also present in the embryonic stem cells from various 
organisms and in cell lines derived from somatic tumors (105-107). 
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Figure 4. Illustration of the LIN28B gene and protein structures. A) Schematic depiction of the exon 
organization of LIN28B and locations of the SNPs associated with pubertal timing assessed in this thesis.  
Line above shows rough genomic position of the gene in humans, green boxes mark exons and dots 
show the relative location of pubertal timing associated SNPs. B) Illustration of locations of the major 
functional domains of the LIN28B protein (numbers refer to amino acids), and C) a picture of the 
interaction between pre-let-7 miRNA and LIN28-protein. CSD=Cold-Shock Domain. Image based on 
data from the UCSC genome browser (108) and an LIN28 image by Piotr Sliz, released under creative 
commons license. 
 
Prior to the GWAS results, neither LIN28B nor the homologous gene LIN28A in humans had 
been thought to contribute to pubertal timing. Nevertheless, remarkably some studies had 
already linked the gene with developmental timing – though in a less complex organism than 
humans, namely the nematode C. elegans (11). In the 1980’s, researchers in Boston 
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performed several forward genetic screens where they induced random mutations to the 
nematodes by chemical methods. When an interesting phenotype following the chemical 
treatment was observed, they mapped the genetic location of the mutation and isolated the 
likely gene behind the phenotype. One of these forward genetic screens targeted mutants 
that caused a “heterochronic” phenotype, meaning that the mutations affected the timing 
of developmental events. These screens led to the identification of several genes, including 
lin-28. The gene was named after the mutational lineage detected in the study - in this case 
lineage 28 (11).  The researchers observed that loss-of-function mutations in lin-28 caused 
premature differentiation of vulval and hypodermal stem cells, and it was later shown that, 
conversely, a gain-of function mutation in lin-28 caused an opposite phenotype, namely 
prolonged cell division in the same cells (11, 104). Importantly, the results from these early 
studies in C. elegans enforced the idea that LIN28B might truly be the causal gene behind 
the GWAS signals. Moreover, they suggested that the links between pubertal timing and 
LIN28B might be related to some fundamental, evolutionarily conserved molecular 
mechanisms that regulate developmental timing and ontogeny across the animal kingdom.  
 
2.3.2 The cellular function of the LIN28 genes: miRNAs, lin28/let-7 
pathway and stem cell biology 
 
The discovery of the heterochronic (=affecting the timing of developmental events) gene lin-
28 was soon coupled with a finding related to its cellular function, again based on work done 
in C.elegans (104, 109). In the nematode, another heterochronic gene, lin-4, had been 
identified, where a loss-of-function mutation caused partially opposite phenotypes 
compared to lin-28 (104, 109).  lin-4 was shown to encode for a small, 21 nt RNA molecule 
that could regulate protein translation by binding to 3’UTR of targets with complementary 
sequences (110). The molecular cause behind the opposing phenotypes of lin28 and lin-4 
mutants began to unravel when it was discovered that lin-28 expression is temporally 
regulated by the lin-4 RNA, acting through a lin-4-complementary element in the lin-28 3ʹUTR 
(104).  Perhaps the most significant finding related to LIN28 function however came in 2000 
when another small RNA, let-7 (lethal 7), was identified as a negative regulator of LIN28 
through a similar mechanism as lin-4, once more in C.elegans (111-113). When 
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overexpressed, let-7 was shown to cause precocious differentiation of cells during larval 
stages, as opposed to the repeated cell division associated with lin28 overexpression (111). 
As a notable exception, whereas lin-4 was found only in the nematode, members of the let-
7 family were found in the genomes of a wide range of metazoans (114).  Besides offering 
insights in the function of lin28, the discoveries of lin-4 and the let-7 were landmarks also in 
terms of the history of cellular biology: these showed the potential of small RNA molecules 
with conserved functions to affect gene expression, marking the discovery of microRNAs 
(miRNA) (110). 
  
A few years after, a hallmark paper was published showing that human fibroblasts could be 
successfully transformed into induced pluripotent stem (iPS) cells (115). This paper, marking 
a completely new era in stem cell research, identified LIN28 as one of the four factors that 
could be used in reprogramming human cells into iPS cells, a feature that has been lately 
shown to apply also to LIN28B (116). This again stimulated plenty of research addressing 
LIN28 function in stem cells in more detail. Soon, LIN28s were shown to inhibit let-7 miRNA 
biogenesis through direct binding to either pre-let-7 and/or pri-let-7 in mammalian cells 
(117-121). As let-7s were now known to repress LIN28 translation, while LIN28s were 
understood to inhibit the biogenesis of let-7 microRNAs, it became clear that such a two-
directional switch could represent a major cellular mechanism governing stem cell renewal 
in multicellular organisms. Since then the concept of lin28/let-7 as a cellular switch 
determining whether the cells continue to divide (situation when lin28 dominates) or 
differentiate (let-7s dominant) has indeed been established as one of the key mechanisms 
that regulates the choice of stem-cell fate. In reality, the molecular features and the 
regulation of this switch in many cells is likely more complex than a simple “LIN28 on – let-7 
off and vice versa” –model implies (122). Keeping this in mind, although a rough consensus 
of the molecular processes whereby the LIN28/let-7 axis affects the regulation of cell division 
has been established (Figure 5), how this is related to more complex biological phenomena 
like pubertal timing remains poorly understood.  
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Figure 5. The main features of the LIN28/let-7 axis and an overview of LIN28B regulation. Whilst LIN28 genes are 
known to promote cell growth and division, let-7 miRNAs are mainly expressed in differentiated cells. At the 
moment it is thought that the axis represents a major switch that determines which gene expression patterns 
dominate in cells. Generally, the situation where LIN28 expression dominates is considered to promote cell 
proliferation and glycolysis at the expense of mitochondrial oxidative phosphorylation (OXPHOS). C-Myc has been 
established as a major driver of LIN28B expression in cancer cells, and NF-kB has been shown to drive LIN28B 
expression upon inflammation. Many downstream effectors of LIN28B including HMGA1 and HMGA2 drive 
conformational changes in chromatin organization affecting the expression of several genes. Figure based on 
reviews by Thornton&Gregory 2012 and Balzeau et al. 2017 (123, 124) 
 
2.3.3 LIN28B as a cancer gene 
 
Cancer is fundamentally a disease of uncontrolled cell division. LIN28B was discovered as a 
gene that was overexpressed in hepatocellular carcinoma, and LIN28B overexpression has 
been since observed in many different types of tumors (103, 107, 123). As it was also known 
that let-7 miRNA expression is usually downregulated in cancer cells, the LIN28/let-7 axis has 
subsequently been studied in pretty much all possible cancer subfields. Cancer research 
represents a significant segment of the whole field of biomedical study, and many research 
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projects have been focused on addressing the genomic mechanisms related to cancer 
incidence and progression. Therefore, it is not surprising that besides the fields of 
developmental and stem cell biology have contributed a lot to the knowledge about the 
molecular mechanisms of LIN28 function, a plethora of research concerning LIN28/let-7 axis 
has been made from the angle of how this axis contributes to cancer formation. Generally, 
these studies have reported upregulation of LIN28/downregulation of let-7 miRNA in cancer 
cells (107, 123). Since LIN28/let-7 axis contribution to cancer has been widely studied, 
several excellent reviews are available around this subject (107, 123, 124). The variety of 
cancers where LIN28/let-7 axis dysregulation has been reported is extensive. Examples of 
these include breast cancer, cervical cancer, gastric cancer, hepatocellular cancer, 
neuroblastomas and prostate cancer (103, 123, 125-128).  At the moment, multiple lines of 
evidence suggest that expression of LIN28 genes may contribute for example to the 
formation of cancer stem cells (CSCs), metastasis, and resistance to chemotherapy and 
radiotherapy (123).  
 
2.3.4 Insights to LIN28 function from animal models 
 
Despite the studies on lin28 in C. elegans providing support for the idea that LIN28B might 
indeed affect the development timing in humans, very little direct evidence linking LIN28B 
with puberty existed at the time of the principal GWAS findings. In fact, as is the case for 
most GWAS loci, although LIN28B was the nearest gene close to the associated SNPs, it 
remained somewhat uncertain whether the actions of this gene were truly behind the 
observed association signal.  However, soon after the original GWAS findings,a landmark 
study, examining the function of Lin28A in mice added evidence for LIN28s capability to 
affect developmental timing  (129). This study revealed how “leaky” overexpression of 
Lin28A yielded similar phenotypes in mice as linked with LIN28B in humans: mice engineered 
to overexpress Lin28A showed delayed maturation, as well as increased size, reflecting the 
human phenotypes associated with LIN28B (129). The leaky overexpression was based on 
introducing an additional copy of Lin28A into a Collagen 1a1 locus. The transgenic mice 
showed proportional overgrowth of all organs, suggesting that an endocrine- or metabolism-
related mechanism might be the cause for the increased size in these mice. Finally, the 
authors showed that Lin28A overexpression led to an enhancement in glycolytic metabolism 
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both in the mice and a myoblast model, suggesting this as the potential reason behind the 
increased growth related to the overexpression of the gene (129). A year later, the same 
group of researchers reported that the Lin28/let-7 axis can modulate glucose metabolism in 
mice, by regulating multiple genes belonging to the insulin-PI3K-mTOR pathway (130). 
Reportedly, both Lin28A and Lin28B transgenic mice manifested increased glucose 
tolerance, and were resistant to obesity, whereas muscle-specific Lin28a knockout mice 
showed opposing phenotypes. However, whether LIN28B could contribute to metabolic 
traits in humans remained still unclear, representing one of the questions addressed in this 
thesis.   
 
Further research utilizing the Lin28A/Lin28B/let-7 mouse models has since then led to some 
other key discoveries.  Based on conditional knockout studies in mice, embryonic LIN28B 
expression seems to have the greatest potential to regulate growth, since LIN28B knockout 
after the fetal stages did not affect mouse size significantly (131). A separate study linked 
Lin28A with tissue regeneration: mice engineered to overexpress Lin28A displayed evidence 
of improved tissue repair (132). Captivatingly, the mice showed increased hair growth after 
shaving, and improvements in digit and ear pinnacle repair following injury.  Up to date, 
similar tissue repair- phenotypes have not been reported for LIN28B. Most recently, sex-
specific growth patterns following Lin28B knockout in mice have been reported: it appears 
that LIN28B affects growth primarily in male mice, reducing both body length and weight 
(131, 133). 
 
In addition to the mice studies, LIN28/let-7 system has been explored in rats. The rat studies 
have been based on models that have examined lin28b expression in the hypothalamus 
under normal and experimental physiological conditions. These studies have reported that 
lin28b levels decline towards sexual maturation in rat hypothalami, suggesting that this 
might somehow be permissive for pubertal onset (134). Nevertheless, also these studies 
have offered relatively little mechanistic insight into the molecular function of Lin28b at the 
time of puberty.  
 
On top of these observations, some efforts have been made to study LIN28 also in other 
animals, yielding partly similar, but also somewhat contrasting results compared to the 
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rodent models. For example, early reports from both the frog Xenopus laevis and zebrafish 
Danio rerio, claimed that knockdown of LIN28 by morpholinos might cause embryonic 
lethality (135, 136). Notably, this type of knockdown method, based on injecting antisense 
nucleotides to embryos differs considerably from the permanent and conditional mouse 
knockout models, as will be discussed in the section 2.4.7. Contrastingly, for example studies 
in Drosophila melanogaster have indicated that lin28 mutants are viable, though have 
defects in oogenesis and muscle formation (137).   
 
Overall, the various model organism studies have significantly advanced our understanding 
of the function and potential pleiotropy of LIN28 genes in the development of vertebrates. 
Yet, most of these studies have not been specifically designed to address the molecular 
mechanisms by which LIN28B genes control sexual maturation. Here, information remains 
still sparse, representing a central gap in knowledge that this thesis aims to fill. 
 
2.3.5 LIN28B, a pleiotropic gene affecting several phenotypes in 
humans 
 
After the association of LIN28B with pubertal timing, it became soon apparent that the gene 
has some distinctive characteristics that make it an interesting subject for further research. 
For instance, the magnitude of the effects associated with genetic variants in the LIN28B 
locus is relatively large, especially in GWAS terms: on average one pubertal timing-advancing 
allele (T) for SNP rs7759938 causes a ~1.5 months advancement in AAM (10, 12, 13). Such a 
large effect on pubertal timing is unusual for common variants. Both pubertal timing 
advancing and pubertal timing delaying alleles in the locus are present in substantial 
frequencies in all studied modern populations: the frequency of the T allele at rs7759938 is 
~ 67% in the Finnish population, causing ~45% of Finns to be homozygous for it. Respectively, 
~44% are heterozygous carriers of the T and pubertal timing delaying (C) allele, and ~11% 
are homozygotes for the C allele (138).  
 
A GWAS addressing the genetics of pubertal growth spurt, performed by our research group 
later showed that the effect on pubertal timing applies to both males and females (9). Since 
then it has become evident that the effects LIN28B exerts on human growth are widespread, 
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and not limited to pubertal timing. Besides puberty, sequence variation in the LIN28B locus 
has been currently linked with several other traits. These include well studied physical 
characteristics such as height, weight, waist and hip circumference, more specific traits such 
as 2D4D finger length ratio, and bone mineral density (BMD), but also disease-related 
phenotypes like intraocular blood pressure, neuroblastoma, insomnia and depression that 
have been linked with LIN28B only recently (15-18, 139-146). The associations are 
summarized in Table 2. The directions of the effects emphasize the complexity of the effects 
LIN28B has on human development. The same variants that delay pubertal onset (and based 
on mouse models show an effect that is likely related to increased LIN28B expression) cause 
an increase in human height, weight and waist and hip circumference.  At the same time, 
they also cause an increase in 2D4D finger length ratio, which has traditionally been thought 
as a marker of prenatal testosterone exposure (high 2D4D = longer index finger compared 
to the ring finger, a feminized phenotype) but also decrease bone mineral density. Disease-
wise, the variants that associate with increased LIN28B expression seem to decrease the risk 
of depression and insomnia, but they also increase intraocular pressure (the main risk factor 
for glaucoma), and the risk for schizophrenia and neuroblastoma. 
 
The work done in mice suggests that LIN28B contribution to cellular metabolism might be 
the cause behind some of the phenotypes associated with LIN28B also in humans (130). 
Notably, most of the traits associated with LIN28B in GWAS are also a subject to hormonal 
regulation (e.g. height, pubertal onset, finger length ratio etc.). Furthermore, there is some 
evidence of sex-specific effects of Lin28B in mice as well as in humans, and neonatal 
estrogenization has been shown to affect Lin28B expression in the rat hypothalamus (133, 
134). Therefore, the possibility that LIN28B might be involved in hormone-dependent 
regulation of vertebrate development in more central ways than perhaps previously 
appreciated should not be excluded, but rather explored in more detail. 
 
2.3.6 The prevalence of protein coding mutations in LIN28B in humans 
 
The current evidence suggests that LIN28B contribution to pubertal timing in the healthy 
population is related to gene expression levels, and does not stem from protein coding 
mutations.  For example the data from the Exome and Genome Aggregation databases (ExAC 
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and GnomAD), indicates that truncating mutations in LIN28B are very rare (138, 147). In the 
ExAC database, only ~1:60,000 individuals seem to carry a protein truncating variant in 
LIN28B, while based on the expected mutation rate, the database might contain at least 8 
such variants (147). Likewise, neither database reports any individuals that are homozygous 
for LIN28B truncating mutations. In humans, such depletion of severe damaging variants is 
often typical for genes affecting neurodevelopmental disorders (148). There are also no 
known high-frequency missense variants in the gene that co-segregate with the pubertal 
timing associated SNPs, and thus such variants in LIN28B gene are unlikely to explain the 
GWAS results.  
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Similarly, it appears that protein coding mutations in LIN28B are not a common cause for 
rare pubertal timing disorders. For example, a study including 145 Finnish patients diagnosed 
with delayed pubertal timing, found no protein coding mutations in LIN28B (149). 
 
2.3.7 Summary of the findings – what we currently know about LIN28B 
 
To summarize, several studies have connected LIN28B with pleiotropic effects on metazoan 
ontogeny and adult phenotypes. The gene has been linked with the regulation of several 
aspects of growth, e.g. organismal size and timing of sexual maturation, and it is known to 
contribute also to several diseases ranging from cancer to mental disorders in humans. 
Currently, knowledge about the biological mechanisms and pathways related to LIN28B is 
based on integration of results from various scientific fields. These fields include 
developmental biology, stem-cell biology, cancer research, various animal models and large 
scale human studies.  Based on these studies, it is now thought that the major function of 
LIN28B is to control cell division and metabolism through the LIN28/let-7 axis. Yet, how and 
whether this molecular function affects the variety of phenotypes associated with LIN28B, 
remains largely unsolved. 
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2.4. From GWAS to biology  
 
2.4.1 The challenge: the gap between the associations and biological 
knowledge 
 
The era of GWAS has marked a substantial advancement for understanding the genetics of 
complex traits. We know now that variation in thousands of genetic loci contributes to the 
heritability of complex traits (20, 86, 150).  Even though the GWAS have provided statistically 
significant and replicable associations with thousands of genetic loci and phenotypes, the 
interpretation of these findings is however currently limited. At the moment, a big challenge 
relates to moving from the GWAS results into understanding the biology behind these 
associations. This challenge essentially provided the motivation also for this thesis. 
 
In order to make the leap from the genetic associations into explaining the biology, it is 
necessary to understand some basic principles of the GWAS design. Although the GWAS 
nowadays include from hundreds of thousands to millions of directly genotyped variants, 
these still represent only a fraction of all variants that exist in the human genomes (20, 85, 
86). With the help of this fraction it is still possible to gain information about most of the 
genome: genetic variants are generally not inherited independently, but form haplotypes 
e.g. sets of genetic variants that are inherited together. In essence the markers used in the 
GWAS, SNPs, can pinpoint a haplotype (a piece of chromosome, a genetic locus) that 
associates with a trait, instead of directly pinpointing a causal sequence variant, or a gene. 
Therefore, in order to identify the causal variant, the biological mechanism and the causal 
tissue behind the association signals, further studies are required (20, 85, 86).  Efforts 
including statistical fine mapping of the genetic locus (i.e. characterizing all sequence 
variation in a given locus by sequencing and/or imputation, followed by statistical analysis 
that leads to prioritization of variants) or prioritization of variants based on functional 
annotations of the human genome can be used to tackle the challenge of identifying the true 
causal variant (151, 152).  This in turn has potential to lead also to the identification of the 
causal gene in the locus, which is similarly challenging. Traditionally, it has been the 
convention that the genes nearest the associated SNP have become the symbol for these 
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associations, even when robust evidence supporting their causality has been lacking. In the 
case of LIN28B and pubertal timing, this assumption has proven likely correct, but for 
example in the case of the most prominent obesity locus, a lot of research was first 
concentrated around FTO as opposed to the IRX3/IRX5 genes that are currently considered 
causal for the obesity phenotypes (153, 154). In essence, without careful analysis and further 
studies it often remains impossible to know from what type of variant, gene and biological 
effect the association stems from. 
 
2.4.2 Essential features of genetic loci contributing to complex traits 
like pubertal timing 
 
Famous studies by RA Fisher showed how in contrast to Mendelian or monogenic traits, 
inheritance of complex traits such as height and pubertal timing could be rather explained 
by the interaction of many genes and environmental effects (155, 156). Similarly, the 
theoretical model shown in Figure 6, as well as the results from several GWAS imply that 
most genetic variants affecting complex traits are fundamentally different compared to the 
variants that have been linked with monogenic disease (86, 155). Whereas the variants 
associated with monogenic disease are usually rare, having large effects on certain traits, the 
variants associated with complex disease are generally common having relatively small 
effects (85, 86, 150, 155). This difference largely stems from the biological properties of the 
associated variants. Mendelian disease is often caused by severe protein truncating variants 
or genomic lesions including insertions, deletions and translocations of genetic material that 
can have dramatic fitness consequences. In contrast, most of the GWAS associated loci 
contributing to complex traits and to normal population variation reside in the non-coding 
parts of the genome. In theory some of these markers might simply tag the effects of 
sequence variants affecting protein structure, but for most loci this seems not to be the case 
(86).  Instead, these complex disease loci most often affect gene regulation (86). This has 
practical consequences also in terms of studying the GWAS loci: it should be carefully 
considered whether it is potential to gain insight into the GWAS associations for example 
from an animal model that utilizes protein truncation to study the function of the gene, or 
whether this type of a model may result in a phenotype that is totally unrelated to the GWAS 
association.  
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Figure 6. Illustration of the fundamental differences between Mendelian and complex traits. Whereas the 
syndromes that cause absent of precocious puberty are often caused by rare mutations that have large fitness 
consequences, the normal variation in pubertal timing between healthy individuals is thought to be largely due to 
aggregation of small genetic effects, often regulatory in nature, around the genome. Interestingly, pubertal timing 
gene MKRN3 gene shows a full spectrum of variants in the human population, ranging from common variants with 
small effects and rare variants with intermediate effects to unique variants causing precocious puberty. Potentially, 
studies that rely on sequencing data have potential to highlight an increasing number of rare variants that may have 
small and intermediate effects on complex traits. Figure based on illustrations by McCarthy et al. 2008, Manolio et 
al. 2009 and Bush 2012 (85, 157, 158). 
 
Another difference between monogenic and complex traits is that instead of clustering 
around a well-defined set of genes, the association signals in complex traits are spread across 
the genome (159). For many complex traits, variants having the largest effects may be 
modestly enriched in specific genes or pathways, but the vast majority of the association 
signals reside close to genes without an obvious connection to disease or trait, like in the 
case of LIN28B and pubertal timing (159). The effects of individual GWAS loci are generally 
small, and when considered collectively they have usually explained only a fraction of the 
genetic variance for a given trait. In the beginning of the GWAS era this was referred to as 
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mystery of missing heritability (157). This mystery has since been partly resolved through 
analyses which have shown that common SNPs with effect sizes below the genome-wide 
significant threshold account for a large proportion of the heritability of many traits (160, 
161). This is reflected in the statistical phenomenon related to GWAS: as the sample size 
increases, more statistically significant findings have been found, but at the same time the 
effect size of the newly discovered loci has decreased. Collectively, these findings imply that 
there indeed exists a huge number of genetic variants that have small effects on complex 
traits. This has led to a hypothesis called an “omnigenic” model (159).  The model states that 
a lot of the heritability for a given trait might be explained by the actions of genes that are 
not directly related to some pivotal pathways, due to interconnected gene regulatory 
networks. Theoretically, within a tissue, any change in gene expression might have 
consequences for the expression of other genes, although a gene may not always “directly” 
affect pathways that are directly responsible of formation of a given trait  (159). 
 
On the other hand, rare genetic variants with larger effect sizes may also contribute to 
genetic variance in complex traits. This has shown to be true especially for severe 
neurodevelopmental diseases such as autism and schizophrenia (162-166). Since on average 
every human carries 60-70 novel sequence variants of which 1-2 are protein coding (147), it 
is likely that in for every human generation also new variants that contribute to complex 
traits emerge. Since human population has increased exponentially over the past century, 
also the number of rare and private variants has increased. This is reflected by the 
observation that huge number of rare and private variants now exist in public databases that 
are based on sequencing thousands of humans (138, 167). Theoretically, the effects of these 
variants range from minuscule to Mendelian effects for an individual, and inevitably such 
variants are likely to explain a proportion of the heritability of complex traits. Therefore, 
whole exome and whole genome sequencing studies (WES and WGS) have potential to 
increase our understanding of the contribution of rare variants to complex traits. For 
example the results from the UK10K consortium and from the ongoing FinnGen project, 
including sequencing data from thousands of humans, have led and will lead to identification 
of several rare and low frequency variants that associate with complex traits, whilst these 
would have been impossible to detect by methods based on genotyping arrays (20). The 
complication is that even with the help of huge cohorts and in the presence of a true 
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biological effect and family information, it is statistically challenging to associate a rare 
variant with small effects with a trait in a robust manner (Figure 6). Despite this complication, 
recently, analyses of whole genome sequencing data have shown that such rare variation, 
that has previously been left understudied, may account for a large proportion (~50%) of 
trait heritability, essentially solving the problem of missing heritability of complex traits 
(168). 
 
2.4.3  eQTL analysis and publicly available genetic databases may 
help to interpret GWAS results 
 
Functional genetic variants can be roughly divided into two categories: 1) Those that cause 
a functional change in protein structure and 2) those that affect the expression level of a 
gene either globally or in a specific tissue. As discussed in the previous chapters, it is now 
thought that since most GWAS hits reside outside coding regions, they most likely tag 
variants affecting gene expression. To assist interpreting the biology behind each GWAS 
locus, characterizing the regulatory elements that reside in the intergenic and intronic 
locations in the human genome is necessary (169). Even without exact knowledge about the 
location of such regulatory elements, examining how genetic variation affects gene 
expression may provide vital hints for understanding the biology behind the associations. 
Usually, this is studied through expression quantitative trait locus (eQTL) analysis. eQTL 
refers to a genetic locus that affects the mRNA expression  levels of a gene or several genes 
in within a tissue. In the past, eQTLs were identified in microarray studies assessing transcript 
abundance, but these have been largely replaced with RNA-seq based methods.  Generally, 
SNPs that have been associated with a trait through GWAS have been shown to be enriched 
for eQTLs, consistent with the hypothesis that many GWAS loci affect gene regulation (170).  
 
Cornerstones for modern genetic research are publicly available genetic databases. These 
range from sequence browsers and variant databases to databases containing information 
about gene expression and published genetic associations.  A central gene expression 
database for this thesis was made available by the Genotype-Tissue Expression (GTEx) 
project (169). The GTEx database has greatly facilitated the study of human gene expression, 
by providing the scientific community with gene expression data from multiple different 
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human tissues. Importantly, the database contains also genotype information, making it 
possible to study whether, and in which way the variants identified through GWAS affect 
gene expression.  At the moment, the database consists from hundreds of individuals and 
thousands of samples from a diverse set of human tissues (169).  
 
Besides gene expression, understanding the phenome-wide consequences of a variant may 
greatly elucidate the biology of a GWAS finding. Phenome-wide association study (PheWAS) 
databases (essentially based on multiple GWAS on different traits in the same cohort(s)) 
contain association results for a single genetic variant against hundreds, if not thousands of 
traits (19, 171). Various databases that allow searching for phenome-wide effects for a 
particular SNP that are emerging (for example those based on the UK biobank- and the 
FinnGen projects) have thus vast potential to offer new insight into studying the GWAS loci.  
 
2.4.4 Model organisms in studying the GWAS loci 
 
Together with the data that is available from the genetic databases, various model organisms 
represent another fundamental asset for genetic and biomedical research. The common 
evolutionary background for all living organisms makes it possible to examine the function 
of genes in one species, and to infer how they function in another. Although the metazoans 
show extensive phenotypic variation, this variation largely stems from fundamental 
molecular mechanisms that are shared with all living creatures. The model organisms used 
to study the function of human genes range from bacteria and yeast to primates. In the past, 
many advances in the field of biosciences have been gained through the study of model 
organisms such as flies and mice.  
 
In its most basic form, the genetic studies of model organisms have involved studying gene 
function by mutagenesis or studying the spatiotemporal expression patterns of a gene. 
Traditionally, the model organism studies have involved knocking out or overexpressing a 
gene and studying its effects on phenotypes. Technological advances have made it possible 
to refine these methods so that nowadays it is for example possible to prepare models that 
introduce a specific nucleotide change, or affect gene expression in selected cells. Different 
animal models have proven indispensable for studying the effects of the genes associated 
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with monogenic disease, often providing vital understanding about potential disease 
mechanisms. Although the GWAS loci identify variants that are partly distinct in nature 
compared to the monogenic disease loci, in many cases various animal models have still 
provided vital insights into the GWAS results. For example in the case of LIN28B, studies 
performed in nematodes and mice have been extremely informative (11, 129, 131). 
 
2.4.5 Zebrafish as a model organism 
 
To study the molecular mechanisms linking LIN28B with growth and sexual maturation, we 
have utilized zebrafish as a model organism in this thesis. Zebrafish are small, tropical 
freshwater fish that have become an increasingly popular model in genetic research over the 
past decades. The “founder” of zebrafish research, George Streisinger originally aimed to 
find a vertebrate model that would be simple to maintain under laboratory conditions, and 
identified zebrafish to suit his needs (172).  Several aspects of zebrafish make them suitable 
for genetic studies. They are easy to breed and generate a large number of offspring, the 
maintenance of the fish is relatively straightforward and cheap, they develop quickly, and 
the external fertilization and transparent embryos make them amenable for genetic 
manipulation (172). An overview of zebrafish life cycle is presented in Figure 7. These central 
benefits of the fish have established zebrafish a one of the key models that are used in 
genetic research at the moment. The number of studies per year using zebrafish has risen 
from ~1000 in year 2000 into ~5000 by 2016, reflecting this popularity (173). The zebrafish 
have been extensively used as model for vertebrate development, tissue regeneration, 
behavior and several diseases, being also a popular model in toxicological studies. Several 
different tools for genetic manipulation of zebrafish have been developed (174). Overall, 
data from mutant screens, reverse genetics and transgenic zebrafish models has led to 
substantial advances in understanding the vertebrate physiology and development.   
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Figure 7. Zebrafish life cycle. The fish develop rapidly, and embryo transparency together with external fertilization 
make zebrafish amenable for many types of genetic analyses.  
 
Many fundamental principles of growth have been conserved in the evolution of vertebrates, 
and for example the molecular pathways underlying development of the hypothalamus have 
been conserved in between fish and mammals(29). Also the function and basic structures at 
the HPG axis are built on similar principles as in mammals(29). The genome of the zebrafish 
has been sequenced, showing easily identifiable orthologues for most mammalian genes 
(175). Some notable genetic differences between the zebrafish and mammals however do 
exist. Teleosts (bony fish, including 96% of extant fish) such as zebrafish have undergone a 
genome duplication event, resulting in additional copies of many genes compared to 
mammals (175). For instance, the latest release of zebrafish genome contains three 
annotated lin28-genes: two orthologues of mammalian LIN28A in chr16 and chr19, and one 
orthologue for LIN28B in chr20 (108, 136, 175). The other genetic feature where the 
zebrafish differ significantly from mammals is the lack of distinct sex chromosomes (175, 
176). Some genetic evidence supports the existence of autosomal loci that contribute to sex 
  
57 
 
determination, but also factors like water temperature and fish density have been suggested 
to affect sex determination of fish (176). These genetic features may underlie some unusual 
abilities that the zebrafish have compared to mammals, like the extensive regenerative 
ability to repair lesions after tissue damage (177). Despite these features of zebrafish, the 
basic molecular mechanisms governing processes like cell proliferation and biological 
principles controlling growth have been widely conserved between zebrafish and humans. 
Although compared to humans zebrafish appear to tolerate damaging mutations in key 
genes affecting reproductive capability, the conservation of the role of the HPG axis in the 
regulation of sexual maturation and reproduction in zebrafish was one of the major reasons 
why it was chosen as the model organism for the studies constituting this thesis (29, 178, 
179).  
 
2.4.6 Ethical aspects regarding zebrafish use in research 
 
The ultimate goal of biomedical research is to understand how living systems work. To this 
end, the information gained from various animal models has proven crucial. The legislation 
concerning animal research is currently strict, and ethical aspects regarding all animal 
models, as well as animal welfare should be carefully considered before any experiment. 
Although in reality the experimental choices always include balancing between scientific 
gains and minimizing animal use, several recommended principles regarding the design of 
animal work exist, like the 3Rs: Replacement, Reduction and Refinement (180, 181). The use 
of zebrafish in research instead of mice and rats is an example of the Replacement principle. 
Zebrafish is considered as a simpler vertebrate than mammals, motivating the use of fish as 
a replacement for mice whenever possible. A good example of such a situation is research 
tackling the fundamental molecular pathways related to vertebrate ontogeny, like the 
studies forming the base of this thesis. The zebrafish have also some other advantages 
compared to many other animals. The oviparity of the fish (meaning that they lay eggs and 
hence embryonic development occurs outside the mother) is another feature of zebrafish 
that makes them especially well-suited for research that is focused on embryonic 
development: it is easy to get zebrafish embryos without harming the mother. This 
advantage together with the transparency of the embryos simplifies studying the immature 
forms of the fish, as a substitute for having to rely on adult individuals, which is another 
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preferred principle in animal research.  The experiments done in fish under 5dpf (roughly 
the age when the zebrafish start to rely on external food sources instead of the nutrition 
provided by the yolk sac) are not subject to legal regulation and do not require an animal 
experiment permit in the EU (Directive 2010/63/EU). The use of fish older than 5dpf requires 
an animal experiment license, and to protect fish welfare and safety, the EU laws concerning 
animal experiments strictly regulate the housing conditions, anesthetic procedures and 
termination of zebrafish (EU document 32014R0377). 
 
2.4.7 Genetic manipulation of zebrafish 
 
Zebrafish have proven very amenable to several types of genetic analysis because of their 
special features discussed in chapter 2.4.5.  In the past, zebrafish have been widely utilized 
in forward genetic screens in which random mutations were induced to fish, and upon 
detection of an interesting phenotype the causal genetic alteration was then mapped leading 
to the identification of several novel genes and pathways affecting vertebrate development 
(182). The classical methods to induce mutations in these forward genetic screens have 
involved radiation, chemical mutagens such as N-ethyl-N-nitrosurea (ENU), retroviruses and 
transposons (174, 182).  
Besides forward genetic screens, particularly the easy access to zebrafish embryos has made 
reverse genetic screens in the organism increasingly popular once suitable tools became 
available. In contrast to the forward screens, the reverse genetic approaches aim at 
modifying a known genomic target instead of inducing random mutations, and subsequently 
following the phenotypic consequences.  Examples of such methods are morpholino 
oligonucleotides (MO) and synthetic mRNA injections, Target Induced Local Lesion in 
Genomes (TILLING), zinc finger nucleases (ZFNs) and the increasingly popular CRISPR-Cas9 
approach (CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats) 
(174, 183). In this thesis, the studies involving zebrafish have been based on three different 
reverse genetic approaches, including gene knockdown by morpholino oligonucleotides 
(MO), gene overexpression by synthetic mRNA injections, and gene knockout by CRISPR-Cas9 
technology. 
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MO are synthetic oligonucleotides that work in anti-sense fashion by binding to target 
mRNAs and subsequently inhibiting mRNA processing or translation (184). MOs, leading to 
transient gene silencing have been extensively used in studies targeting early development 
since they are easy to apply by microinjections into fertilized zebrafish eggs. However, like 
all anti-sense technologies, in many cases also MOs have proven to cause unwanted off-
target effects, and only a fraction of the phenotypes associated with MO use have been 
replicated in studies using different mutational strategies (184, 185). Accordingly, the use of 
MOs requires great care and with the invention of novel mutagenic strategies has become 
less popular. The complementary method to MO induced gene silencing, synthetic mRNA 
injections, aimed to overexpress a gene seems to be better tolerated by the cells compared 
to MOs, though like in the case of MOs these may also cause unwanted cell toxicity if injected 
in two high concentrations (186).  
CRISPR-Cas9 induced mutagenesis has meant a revolution for the genetic manipulation of 
organisms (187). The method is based on a RNA-directed endonuclease complex that 
generates double stranded breaks (DSB) in to DNA, representing a prokaryotic immune 
defence mechanism against viruses (187). The endonuclease consists of two main 
components, RNA sequence matching a genomic target site and Cas9 protein that is capable 
of cutting DNA. The genetic manipulation methods in zebrafish using this system usually 
involve generating a guide RNA (gRNA) that targets a specific genomic sequence, and co-
injecting this with RNA molecules encoding for Cas9 protein into 1-cell stage embryos (183). 
In its basic form, the CRISPR-Cas9 method generally results in creation of a DSB that is quickly 
but inaccurately repaired by the cells. Usually this results in small 
deletions/insertions/mismatches in the target site, disrupting the target gene. However, the 
method can be used also to induce specific mutations into the target site (gene knock-in) 
(183). Despite the reported high specificity of the method in creating the desired genetic 
lesion, similarly to other mutational methods, potential off-target effects of the CRISPR-Cas9 
technique have to be considered when designing an experiment (174, 183, 187). In practice, 
a couple of simple measures to control for CRISPR-Cas9 off-target effects exist. First, one 
may create multiple mutations to the same gene, using different target sequences, and 
check whether these have similar phenotypic consequences. Secondly, in case of using a 
model organism, the resulting genetic lesion should not be studied in the F0 generation, but 
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F0 organisms should be rather outbred to wild-type background before assessing the 
phenotype. Despite these caveats, due to its reliability, low cost, relative ease and high 
specificity CRISPR-Cas9 technique has become the gold standard to study gene function in 
animal models (187).   
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3 Aims of the study 
Over the past decade, advances in the field of genetics have led to identification of huge 
number of genetic variants that affect complex traits. Through GWAS, our group has been 
involved in the discovery of common variants that associate with changes in pubertal timing 
in the healthy population. However, understanding the causal biological mechanisms behind 
these associations represents a major challenge.  The overall aim of my thesis has been to 
explore how we can move from the GWAS results to the next level: to move from the 
association signals into decoding the underlying biological mechanisms. Particularly, in this 
thesis project I have focused on understanding the molecular mechanism by which LIN28B 
affects the timing of sexual maturation in humans and other vertebrates.  
The specific aims of this thesis were: 
I) To assess whether pubertal timing associated sequence variants near LIN28B contribute 
to body size and metabolic profiles in adult humans (Study I) 
II) To understand how the pubertal timing associated sequence variation affects LIN28B 
expression and whether this has consequences on the function of the HPG-axis (Studies II 
and III) 
III) To create lin28b knockdown, overexpression and knockout models in zebrafish 1) to 
assess how these affect fish growth and 2) to explore the fundamental molecular 
mechanisms by which LIN28B might affect the timing of sexual maturation and growth in 
vertebrates (Studies II and III) 
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4. Materials and Methods 
4.1 Subjects (Study I) 
 
The study I was based on subjects from the Finnish National FINRISK study. The FINRISK 
studies belong to a series of Finnish population-based surveys and have been performed 
since 1972 at five-year intervals. The main objective of the FINRISK studies is to characterize 
risk factors for non-communicable disease (188). The subjects in the FINRISK cohorts have 
been collected from six distinct geographical regions in Finland. The cohorts have been 
designed to include at least 200 subjects of each sex in 10-year age groups (range 25 to 74 
years) from each region. The study I included altogether data from 26,635 subjects (5,616 
subjects from FINRISK 1992, 6,869 from FINRISK 1997, 8,257 from FINRISK 2002 and 5,908 
subjects from FINRISK 2007). All the subjects had been genotyped. All participants had given 
a written informed consent of participation, and the study protocols had been approved by 
the institutional ethical review boards of the National Institute for Health and Welfare, and 
the Helsinki University Hospital, Helsinki, Finland. 
 
4.2 Data collection and genotyping (Study I) 
 
The participants of the FINRISK studies had been invited to a health inspection during which 
height, weight, waist and hip circumferences were measured by trained nurses using 
standardized procedures (188). For 94 and 92 subjects included in the Study I height and 
weight were self-reported. Before the inspection, the participants had been instructed to 
fast for at least four hours. The protocol included taking blood samples for 1) DNA extraction 
2) determination of blood lipids and 3) assessing blood lipoprotein concentrations. For a 
subset of subjects from FINRISK 2007, blood glucose and insulin were measured during an 
oral glucose tolerance test based on ingesting 75 g of glucose. Descriptive cohort statistics 
are shown in Table 3. 
 
The study subjects were genotyped for SNPs rs7759938 and rs314279 using a Sequenom 
MassARRAY genotyping platform (Sequenom Inc., San Diego, USA). Genotypes were 
automatically called with Typer 4.0 Analyzer software, and the clustering of the genotypes 
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was manually checked. For both markers, the success rate for genotyping was >98%. The 
minor allele frequencies (MAF) in the sample were 0.32 for rs7759938 and 0.13 for rs314279. 
We observed a pair-wise correlation (r2) of 0.3 between the markers. For all the participating 
cohorts, the genotype frequencies were in Hardy-Weinberg equilibrium at both loci. 
 
Table 3. Descriptive statistics of the cohorts included in study I 
 
FINRISK 1992 Men   Women    
Response Variable n Mean (SD) Min Max n Mean (SD) Min Max 
Age(yrs) 2589 44.8 (11.1) 25 64 3027 44.8 (11.4) 25 64 
Height(cm) 2589 176.1 (6.8) 148.0 202.0 3026 162.5 (6.1) 130.0 182.0 
Weight(kg) 2589 82.5 (13.0) 46.5 154.0 3026 67.9 (12.6) 36.0 137.0 
BMI(kg/m2) 2589 26.6 (3.9) 17.5 53.3 3025 25. 8 (4.9) 15.4 52.0 
Waist(cm) 2587 94.1 (11.3) 64.0 144.0 3027 80.4 (11.7) 58.0 139.0 
Hip(cm) 2586 101.7 (6.6) 51.0 153.0 3026 101.7 (8.7) 80.5 148.0 
WHR 2586 0.92 (0.07) 0.65 1.67 3025 0.79 (0.07) 0.62 1.09 
Cholesterol (mmol/l) 1692 5.8 (1.1) 2.4 10.5 2000 5.6 (1.1) 2.4 10.3 
HDL (mmol/l) 1693 1.3 (0.3) 0.5 2.7 2000 1.53 (0.34) 0.5 2.7 
APOA1 (g/l) 229 1.36 (0.23) 0.38 2.04 346 1.46 (0.24) 0.64 2.21 
APOB (g/l) 297 1.02 (0.23) 0.44 1.90 419 0.96 (0.23) 0.49 1.80 
Triglycerides (mmol/l) 1693 1.9 (1.3) 0.4 12.8 2000 1.30 (0.87) 0.2 14.9 
        
FINRISK 1997 Men   Women    
Response Variable n Mean (SD) Min Max n Mean (SD) Min Max 
Age(yrs) 3236 48.8 (13.5) 25 74 3619 47.4 (12.9 25 74 
Height(cm) 3186 175.5 (7.1) 134.0 204.0 3619 162.3 (6.4) 139.0 192.0 
Weight(kg) 3185 83.0 (13.2) 40.0 150.0 3609 69.3 (13.3 37.1 137.8 
BMI(kg/m2) 3184 27.0 (4.0) 14.7 48.4 3608 26.4 (5.1) 14.7 49.4 
Waist(cm) 3230 94.6 (11.4) 64.5 149.0 3633 81.9 (12.4) 58.0 133.5 
Hip(cm) 3228 101.9 (6.8) 77.0 146.5 3619 101.8 (9.2) 69.5 159.0 
WHR 3228 0.93 (0.07) 0.68 1.20 3608 0.80 (0.07) 0.61 1.38 
Cholesterol (mmol/l) 2085 5.6 (1.0) 2.8 10.0 2466 5.6 (1.1) 2.6 9.7 
HDL (mmol/l) 2085 1.3 (0.3) 0.4 2.8 2466 1.5 (0.4) 0.5 3.0 
APOA1 (g/l) 1997 1.50 (0.26) 0.35 2.61 2349 1.72 (0.30) 0.48 2.97 
APOB (g/l) 1998 1.06 (0.25) 0.21 2.09 2350 0.99 (0.25) 0.30 2.04 
Triglycerides (mmol/l) 2085 1.7 (1.1) 0.3 11.4 2466 1.3 (0.8) 0.3 11.4 
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BMI = Body mass index, WHR = Waist to hip ratio, ApoA1 = Apolipoprotein A1, ApoB = Apolipoprotein B, FP = 
Fasting Plasma, 2H glucose = Plasma glucose concentrations 2 h after a 75g oral glucose load, FS = fasting serum 
 
 
 
FINRISK 2002 Men   Women    
Response Variable n Mean (SD) Min Max n Mean (SD) Min Max 
Age(yrs) 3828 48.9 (13.1) 25 74 4429 47.5 (13.2) 25 74 
Height(cm) 3828 175.7 (6.8) 154.0 202.0 4426 162.4 (6.3) 110.0 196.0 
Weight(kg) 3828 84.3 (14.0) 48.7 174.0 4426 69.9 (13.5) 38.3 145.4 
BMI(kg/m2) 3828 27.3 (4.1) 17.0 56.0 4425 26.5 (5.1) 15.8 53.5 
Waist(cm) 3824 95.5 (11.8) 59.0 158.0 4389 83.9 (12.7) 56.5 139.0 
Hip(cm) 3827 98.6 (7.5) 76.5 141.0 4388 99.7 (10.1) 73.0 149.5 
WHR 3824 0.97 (0.07) 0.59 1.25 4388 0.84 (0.07) 0.63 1.34 
Cholesterol (mmol/l) 2510 5.8 (1.1) 2.8 10.4 3042 5.6 (1.0) 3 10.5 
HDL (mmol/l) 2509 1.4 (0.4) 0.3 3.1 3038 1.7 (0.4) 0.5 3.2 
APOA1 (g/l) 2507 1.45 (0.25) 0.80 2.89 3033 1.63 (0.29) 0.65 2.85 
APOB (g/l) 2507 1.06 (0.25) 0.32 2.18 3033 0.96 (0.23 0.25 2.13 
Triglycerides (mmol/l) 2510 1.7 (1.1) 0.3 14.2 3043 1.2 (0.7) 0.3 6.9 
FINRISK 2007 Men   Women    
Response Variable n Mean (SD) Min Max n Mean (SD) Min Max 
Age(yrs) 2753 51.2 (13.9) 25 74 3155 50.2 (14.0) 25 74 
Height(cm) 2753 176.0 (6.9) 152.0 218.0 3155 162.8 (6.3) 137.0 185.0 
Weight(kg) 2753 84.9 (14.2) 47.5 193.3 3155 71.1 (14.3) 40.1 153.0 
BMI(kg/m2) 2753 27.4 (4.2) 16.0 63.3 3155 26.9 (5.4) 16.4 53.1 
Waist(cm) 2748 98.1 (12.0) 66.5 173.5 3106 87.9 (13.7) 60.0 142.0 
Hip(cm) 2746 100.3 (7.7) 77.0 161.0 3106 101.6 (11.0) 75.5 162.0 
WHR 2746 0.98 (0.07) 0.78 1.25 3105 0.86 (0.06) 0.69 1.15 
Cholesterol (mmol/l) 1751 5.4 (1.0) 2.2 9.4 2210 5.4 (1.0) 2.6 10.0 
HDL (mmol/l) 1750 1.3 (0.3) 0.5 3.0 2210 1.6 (0.4) 0.7 3.1 
APOA1 (g/l) 1751 1.52 (0.25) 0.68 2.66 2210 1.70 (0.29) 0.87 2.92 
APOB (g/l) 1751 0.99 (0.22) 0.15 1.91 2210 0.91 (0.22) 0.31 1.93 
Triglycerides (mmol/l) 1751 1.6 (1.0) 0.3 10.8 2210 1.2 (0.7) 0.3 8.4 
FP Glucose (mmol/l) 1853 5.88 (0.45) 4.30 7.00 2302 5.60 (0.46) 4.24 6.98 
2H Glucose (mmol/l) 1841 6.12 (1.70) 2.30 11.03 2233 6.25 (1.64) 2.07 11.09 
FS Insulin (mU/l) 1880 6.58 (3.41) 2.40 25.90 2253 6.13 (3.19) 2.40 25.60 
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4.3 Experimental animals (Studies II and III) 
 
Zebrafish for all experiments in studies II and III were obtained from the “Turku” strain, 
maintained in the Panula laboratory (Department of Anatomy and Neuroscience Center, 
University of Helsinki) for almost two decades (189, 190). Embryos, larvae and adult 
zebrafish were raised and maintained at in a 14h/10h light/dark cycle at 28 °C. Zebrafish 
embryos and larvae were raised in 1xE3 medium (5.00mM NaCL, 0.44mM CaCl2 0.33mM 
MgSO4 and 0.17mM KCl. After seven days, the fish were transferred into system water. Fish 
husbandry was performed in the Panula laboratory at all times. Larval fish were fed SDS dry 
food (SDS Diets, Essex UK) once a day. Starting from 14 dpf the feeding occurred twice a day 
including also artemia (Great Salt Lake Artemia Cysts, Sanders, USA).  To collect samples for 
experiments, the larvae, juvenile and adult fish were either first killed with ice-cold water, 
or they were anesthetized with 0.03% tricaine and killed by dissecting the brain. The well-
being of the fish was monitored regularly and neither sick, injured, nor deformed fish were 
used in the experiments.  The experiments were conducted in the Zebrafish Unit in the 
University of Helsinki Neuroscience center supported by Biocenter Finland, with permission 
from the Animal Experiment Board of the Regional State Administrative Agency of Southern 
Finland (ESAVI/7434/04.10.07/2016), in agreement with the ethical guidelines of the 
European convention for the protection of vertebrate animals used for scientific purposes.  
 
4.4 Microinjections to dysregulate lin28b (Study II) 
 
In study II, we utilized microinjections into 1-cell stage zebrafish embryos to dysregulate 
lin28b expression transiently during the embryogenesis. The microinjections that we used 
contained either morpholino oligonucleotides (MO) to downregulate lin28b expression, or 
synthetic lin28b mRNA to increase lin28b expression. We designed antisense morpholino 
oligonucleotides (MO) to target the initiator codon and a splice donor site between exon 1 
and exon 2 of lin28b (lin28b MO1, 5ʹ GCGCGGCCCTCCTTCGGCCATGTTTʹ3; lin28b MO, 
5ʹCCCTCCTGTGCGGTCAAGAGAGAAAʹ3. These and a p53-blocking MO and a standard control 
MO (ctrl) (p53 5ʹGCGCCATTGCTTTGCAAGAATTGʹ3, ctrl 5ʹCCTCTTACCTCAGTTACAATTTATAʹ3) 
were obtained from Gene Tools LLC, Philomath, OR. For the injections, we tested several 
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different concentrations of the morpholinos, ranging from 0.75 ng to 6 ng/embryo. The MO 
binding over the splicing site between lin28b exon1 and exon2, preventing normal mRNA 
processing and protein translation was used in most of the experiments. We performed 
extensive quality control to counteract potential off-target effects associated with MO use.  
First, we assessed the dose response curves of several MO doses in order to avoid using MO 
concentrations that would result in lethality or gross developmental defects for the majority 
of the embryos. Secondly, mRNA rescue experiments co-injecting MO and mRNA were 
utilized to assess the specificity of the observed phenotypes. The inhibition of lin28b mRNA 
in zebrafish embryos by MOs was finally confirmed by qPCR.   
 
In order to produce the synthetic lin28b mRNA used in the injections, we first had to clone 
and characterize the full-length lin28b transcript from zebrafish. lin28b full-length open 
reading frame cDNA constructs were prepared by RT-PCR using Phusion High-Fidelity PCR 
Master Mix (Thermo Fischer Scientific, Waltham, MA). Primers F 5ʹGATTTCGCTGGAACTTTGʹ3 
and R 5ʹCTGTTTGAGGTAGATGATTTCʹ3, amplifying the whole predicted open reading frame 
(ORF) of lin28b (213aa) + 126bp of 5ʹ and 58bp of 3ʹ UTR, were used to isolate the full-length 
lin28b coding sequence. The amplified PCR products were subsequently cloned into pGEM-
T Easy vector (Promega, Madison, WI) and successful insertion of the lin28b fragment in to 
the plasmid was verified by sequencing. The insert sequence was then transferred from the 
pGEM-T easy into plasmid pMC (donated to Panula laboratory by Dr. Thomas Czerny). The 
pMC plasmid was linearized with Thermo Fisher Scientific Fast Digest NotI to allow for mRNA 
synthesis. mMESSAGE mMACHINE T7 kit (Ambion, Austin, TX) was subsequently used to 
synthesize full-length lin28b ORF transcripts. Finally, the resulting synthetic mRNA was 
injected into zebrafish embryos in concentrations ranging from 125 pg to 1 ng per embryo. 
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4.5 Generation of lin28b mutant zebrafish using CRISPR-Cas9 system 
(Study III) 
 
In order to create lin28b knockout zebrafish, we designed two CRISPR-Cas9 models targeting 
exon1 and exon3 of zebrafish lin28b. The target site for exon1 was 5’-
GGAGGGTCCGCGGGGAAACA-3’ and for exon3 5’-GGCTTCAGGAGCCTGCGGGA-3’  
For mutant generation, 30 zebrafish embryos (F0) were injected with 600pg Cas9 mRNA and 
50pg exon1 or 25pg exon3 gRNA. The injection mixtures are described in Table 5. Mutations 
in lin28b were induced in approximately 80% of F0 fish, based on collecting and sequencing 
5 potentially mosaic F0 embryos per sample. At 30 days of age, the remaining fish were 
genotyped for lin28b mutations from tail fin samples, and the fish showing the presence of 
potential mutations based on sequence analysis were grown into adulthood. Assuming that 
for some of these fish the mutations were present also in the germline cells, the F0 zebrafish 
were mated back into the Turku strain to obtain zebrafish that might be heterozygous 
carriers of lin28b mutations. These F1 zebrafish were subsequently screened for the 
presence of lin28b mutations, and once present, they were grown and genotyped from tail 
fin samples. In case the fish carried an interesting mutation, these fish from the F1 
generation were crossed to obtain F2 control (+/+), heterozygous (+/-) and KO (-/-) (KO) 
zebrafish for the analyses. Both CRISPR-Cas9 models (targeting either lin28b exon1 or exon3) 
produced mutant fish that were used to generate the data for the study. The “exon1” lin28b 
KO fish were homozygous for a 4bp deletion + one bp mismatch including deletion of the 
ATG-initiation codon in the full length lin28b transcript. The “exon3” fish were compound 
heterozygous for mutations that either deleted 10bp from the exon3, or inserted 10bp + 3 
mismatches into the canonical zebrafish lin28b sequence. All the mutations were predicted 
to lead to generation of truncated lin28b proteins. The presence of the mutations in the 
knockout fish were confirmed by cDNA sequencing (Figure 8) and mutated sequences are 
listed in Appendix 1.  
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Figure 8. Sequencing traces from cDNA of lin28b exon1 + exon3  KO fish with control traces  shown.  The traces 
show the presence of mutations in the KO fish, leading to introduction of premature stop codons in the mRNA 
(data not shown). Red lines and circles indicate mutated bases, and black lines mark exon boundaries.  
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Appendix 1. Annotated zebrafish lin28b cDNA sequences showing the locations of CRISPR-Cas9 
induced mutations.  
A) Wild-type lin28b cDNA sequence. Primer locations shown in green, 5’ and 3’ UTR shown in lower case letters 
and exons in uppercase. * denotes exon boundary.  
B) cDNA sequence for exon1 mutant fish, showing the deletion of four bases overlapping the translation intiation 
codon (ATG) and one mismatch (C>T). The only other potential intiation codon encoding for lin28b related 
transcript bolded and highlighted on red. The truncated protein potentially produced using this site would not 
contain the cold-shock and zinc-finger domains crucial for lin28b function. 
C) cDNA sequence of exon3 mutant fish A, showing the deletion of 10 bases in lin28b exon 3. Premature stop 
codon bolded and highlighted in red. 
D) cDNA sequence of exon3 mutant fish B, showing the insertion of 10 bases (red) + 3 mismatches (orange) 
compared to the wild-type sequence. Premature stop codon bolded and highlighted in red. 
A)5’gatttcgctggaactttggaacggagggtccgcggggaaacATGGCCGAAG*GAGGGCCGCGCAGAGGTGGCGGGTCGGACACCGCCAGGACTCCGCCG
CAGAGTCTGTCTGGCTCGGGTTACTGCAAGTGGTTCAATGTCCGCATGGGGTTTGGATTTATATCGATGACCAGCAGCGAGGGGAAGCCAGTGGACCCTCCGC
TAGACGTGTTCGTTCACCAAAGTAAGCTGGTGATGGAG*GGCTTCAGGAGCCTGCGGGAGGGCGAGCAGGTGGAGTTCACCTTTAAGAGGTCGAGTAAAGGTC
TGGAGTCGCTCCGGGTGACGGGGCCCGGGGGAGGCCCCTGCTCTGGCAGCGAGCGACGCCCCAAAGCAAAGGCCCCGCCCCTCAAACGCAAACCAAAGGGAGA
CCGGTGTATAACTGTGGAGGTCTGGACCACCACGCTAAAGAGTGTGGCCTTCCACCCCAGCCAAAGAAGTGTCACTACTGTCAGAGTGTCACGCACATGGTGG
CCCAGTGTCCCCACAAGGGGGCGCCGTCGCCCTCCGCGTCTCAGGACCCGCAACGCCCCTCCACCTCCGCTCAGTCCCCGGAAGAGGAAAGCCGCTCAGGCTC
ATCTTCATCCCCGGAGGAGGCTTCTCAAAGAGGGAGTCGCTCCCAGCGCTGGAGAAAGAGCCGGGACTGAaacaaacacacctctcatccagaccaggcccgg
acacgaaatcatctacctcaaacag3’ 
 
B)5’gatttcgctggaactttggaacggagggtccgcggggaa----GGTCGAAG*GAGGGCCGCGCAGAGGTGGCGGGT 
CGGACACCGCCAGGACTCCGCCGCAGAGTCTGTCTGGCTCGGGTTACTGCAAGTGGTTCAATGTCCGCATGGGGTTTGGATTTATATCGATGACCAGCAGCGA
GGGGAAGCCAGTGGACCCTCCGCTAGACGTGTTCGTTCACCAAAGTAAGCTGGTGATGGAG*GGCTTCAGGAGCCTGCGGGAGGGCGAGCAGGTGGAGTTCAC
CTTTAAGAGGTCGAGTAAAGGTCTGGAGTCGCTCCGGGTGACGGGGCCCGGGGGAGGCCCCTGCTCTGGCAGCGAGCGACGCCCCAAAGCAAAGGCCCCGCCC
CTCAAACGCAAACCAAAGGGAGACCGGTGTATAACTGTGGAGGTCTGGACCACCACGCTAAAGAGTGTGGCCTTCCACCCCAGCCAAAGAAGTGTCACTACTG
TCAGAGTGTCACGCACATGGTGGCCCAGTGTCCCCACAAGGGGGCGCCGTCGCCCTCCGCGTCTCAGGACCCGCAACGCCCCTCCACCTCCGCTCAGTCCCCG
GAAGAGGAAAGCCGCTCAGGCTCATCTTCATCCCCGGAGGAGGCTTCTCAAAGAGGGAGTCGCTCCCAGCGCTGGAGAAAGAGCCGGGACTGAaacaaacaca
cctctcatccagaccaggcccggacacgaaatcatctacctcaaacag3’ 
 
C)5’gatttcgctggaactttggaacggagggtccgcggggaaacATGGCCGAAG*GAGGGCCGCGCAGAGGTGGCGGGTCGGACACCGCCAGGACTCCGCCG
CAGAGTCTGTCTGGCTCGGGTTACTGCAAGTGGTTCAATGTCCGCATGGGGTTTGGATTTATATCGATGACCAGCAGCGAGGGGAAGCCAGTGGACCCTCCGC
TAGACGTGTTCGTTCACCAAAGTAAGCTGGTGATGGAG*GGCTTCAGGAG----------
GGCGAGCAGGTGGAGTTCACCTTTAAGAGGTCGAGTAAAGGTCTGGAGTCGCTC 
CGGGTGACGGGGCCCGGGGGAGGCCCCTGCTCTGGCAGCGAGCGACGCCCCAAAGCAAAGGCCCCGCCCCTCAAACGCAAACCAAAGGGAGACCGGTGTATAA
CTGTGGAGGTCTGGACCACCACGCTAAAGAGTGTGGCCTTCCACCCCAGCCAAAGAAGTGTCACTACTGTCAGAGTGTCACGCACATGGTGGCCCAGTGTCCC
CACAAGGGGGCGCCGTCGCCCTCCGCGTCTCAGGACCCGCAACGCCCCTCCACCTCCGCTCAGTCCCCGGAAGAGGAAAGCCGCTCAGGCTCATCTTCATCCC
CGGAGGAGGCTTCTCAAAGAGGGAGTCGCTCCCAGCGCTGGAGAAAGAGCCGGGACTGAaacaaacacacctctcatccagaccaggcccggacacgaaatca
tctacctcaaacag3’ 
 
D)5’gatttcgctggaactttggaacggagggtccgcggggaaacATGGCCGAAG*GAGGGCCGCGCAGAGGTGGCGGGTCGGACACCGCCAGGACTCCGCCG
CAGAGTCTGTCTGGCTCGGGTTACTGCAAGTGGTTCAATGTCCGCATGGGGTTTGGATTTATATCGATGACCAGCAGCGAGGGGAAGCCAGTGGACCCTCCGC
TAGACGTGTTCGTTCACCAAAGTAAGCTGGTGATGGAG*GGCTTCAGGAGCCTTCAGGAGCCTTCAGGAGGGCGAGCAGGTGGAGTTCACCTTTAAGAGGTCG
AGTAAAGGTCTGGAGTCGCTCCGGGTGACGGGGCCCGGGGGAGGCCCCTGCTCTGGCAGCGAGCGACGCCCCAAAGCAAAGGCCCCGCCCCTCAAACGCAAAC
CAAAGGGAGACCGGTGTATAACTGTGGAGGTCTGGACCACCACGCTAAAGAGTGTGGCCTTCCACCCCAGCCAAAGAAGTGTCACTACTGTCAGAGTGTCACG
CACATGGTGGCCCAGTGTCCCCACAAGGGGGCGCCGTCGCCCTCCGCGTCTCAGGACCCGCAACGCCCCTCCACCTCCGCTCAGTCCCCGGAAGAGGAAAGCC
GCTCAGGCTCATCTTCATCCCCGGAGGAGGCTTCTCAAAGAGGGAGTCGCTCCCAGCGCTGGAGAAAGAGCCGGGACTGAaacaaacacacctctcatccaga
ccaggcccggacacgaaatcatctacctcaaacag3’ 
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Table 4. Primers, cycling conditions and target sequences used in the generation and analysis of 
the lin28b knockout zebrafish. 
 
Mutant 
strain 
 
PCR primers for mutation sequencing PCR cycling conditions for sequencing 
exon1 F: 5'-TACAAACAACGTAAACAAAG-3'; R:5'-
AAAGAGACATGACTAAATATC-3' 
95°C 3min; 35x(95°C 30s, 55°C 30s, 
72°C 1min); 72°C 10min 
exon3 F: 5'-GACTCCAGACCTTTACTC-3'; R: 5'-
TATACAAGAACGCCTGAT-3' 
95°C 3min; 35x(95°C 30s, 55°C 30s, 
72°C 1min); 72°C 10min 
 
HRM primers for mutation detection HRM cycling conditions 
exon1 NA NA 
exon3 F: 5'-CCTCTTAAAGGTGAACTCCA-3'; R:5'-
GGGTGTAATAAATATACAAGAACG-3' 
95°C 5min; 40x(95°C 30s, 55°C 30s, 
72°C 30s); 72°C 10min 
 
Primers for lin28b amplification from the 
cDNA of the mutant fish 
PCR cycling conditions for cDNA 
sequencing 
exon1 
and   exon3 
F:5'-GATTTCGCTGGAACTTTG-3'; 
R:5'CTGTTTGAGGTAGATGATTTC-3' 
95°C 3min; 35x(95°C 20s, 55°C 20s, 
72°C 30s); 72°C 10min 
 
guideRNA Target Sequence 
 
exon1 5’-GGAGGGTCCGCGGGGAAACA-3’  
 
exon3 5’-GGCTTCAGGAGCCTGCGGGA-3’  
 
 
Table 5. Injection mixtures to create CRISPR-Cas9 induced lin28b mutations to F0 zebrafish. 
 
Compound CRISPR-Cas9 Injection 
mixture lin28b-exon1 (194,7ng/μl) 
CRISPR-Cas9 Injection 
mixture lin28b-exon3 (98ng/μl) 
sgRNA exon1 0.5μl (195ng/μl) 0 
sgRNA exon3 0 0.5μl (98ng/μl) 
Cas9 mRNA 2μl (592ng/μl) 2μl (592ng/μl) 
phenol red 0.7μl 0.7μl 
H20 0.5μl 0.5μl 
total 3.7μl 3.7μl 
 
4.6 Analysis of fish growth (Studies II and III) 
 
In study II, we characterized the growth of the zebrafish in two separate experiments. The 
first experiment included analyzing fish length and head circumference at 6d, and the other 
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examined fish growth from juveniles to puberty (60-120d). The experiments including 
measuring fish size were performed with the researcher taking measures blinded for the fish 
group. Puberty and sex were assessed by examining the growth of gonads following the 
guidelines from(70), with egg production determined as visible eggs upon dissecting female 
fish. For the second experiment comparing fish size during juvenile growth the number of 
fish per tank (tank size = 3 L) was kept similar between the groups (ranging between 7 vs. 7 
fish to 20 vs. 21 fish). Each fish used in study II was measured only once at a single timepoint 
(i.e. we did not follow the growth of individual fish). 
In study III, we characterized lin28b KO fish growth with two experiments. We first assessed 
larval fish size at 5d, and secondly we followed the growth of fish between 30dpf and 240dpf. 
In the first experiment we measured altogether 201 5-day old fish for body length and head 
circumference. In second experiment, we measured fish length and weight at 30d intervals 
(weight was measured starting from 120dpf). The fish in the second experiment were 
genotyped from tail fin samples either by sequencing (exon1) or by High-Resolution-Melting 
curve analysis (HRM) (exon3) at each time point. HRM analysis is based on different melting 
temperatures of PCR products overlapping the mutation site from wild-type, heterozygous 
and homozygous mutant samples. Therefore, it is possible to detect sample genotype in a 
simple real-time PCR reaction without additional sequencing steps or special reagents. The 
primers used in sequencing and HRM and cycling conditions are shown in Table 4. In both 
experiments, lin28b knockout and control fish were grown together. In the second 
experiment the fish were grown in three 5 liter tanks. Two of the tanks contained exon1 KOs 
and control fish, (starting N=32 and 34 fish per tank), and one contained exon3 KOs and 
controls N=38).  The researcher measuring and sequencing the fish was always blinded for 
their genotype information.  
 
4.7 RNA extraction, cDNA synthesis and qPCR (Studies II and III) 
 
In studies II and III, total RNA was extracted using miRNeasy mini Kit (Qiagen Inc., Valencia, 
CA) according to the instructions of the manufacturer. In study II the RNA was extracted 
either from 20 to 25 pooled embryos/larvae collected at 1, 2, 3 and 5-dpf, or from the 
individual brain of 120d old fish. In study III, RNA was extracted either from 6-11 pooled 1d 
  
72 
 
or 7d samples (RNA sequencing) or from the single brain/pituitary of a 130d old fish. In study 
II, 0.5–1.5 μg of RNA, and in study III 0.1-0.2μg of RNA was reverse-transcribed using the 
SuperScript® VILO cDNA Synthesis Kit to yield the cDNA for the qPCR experiments. In study 
III, the 1d and 7d samples subjected to RNA sequencing were DNAse treated, showing 
median RNA Integrity Number (RIN) >9.5.  
 
In both studies II and III, qPCR was performed with the Light Cycler® 480 (F. Hoffmann-La 
Roche Ltd, Switzerland) instrument using iQ™ SYBR® green Supermix (Bio-Rad, Hercules, CA) 
(Study II) or Roche Light Cycler 480 SYBR Green I master mix (Study III) as instructed (F. 
Hoffmann-La Roche Ltd, Switzerland). In study II, 0.5 μl of 5 mM primers and 1 μl of 1:14 
dilution of the cDNA was used per 10 μl qPCR reaction, whereas in study III we utilized 0.75 μl 
of 5 mM primers and 2 μl of 1:10 dilution of the cDNA per 15 μl qPCR reaction Primers for 
amplification were designed with Sigma OligoArchitect™ and Primer-BLAST (NCBI). Primer 
sequences and cycling conditions are shown in Table 6. Fluorescence changes were 
monitored after every cycle. Dissociation curve analysis was performed to ensure only a 
single amplicon was obtained. Results were obtained with the LightCycler® 480 software and 
after quality control, data were normalized and calculated based on Ct values. Reactions 
were run up as duplicates and relative expression levels were calculated based on b-actin 
(study II&III) and eif-1a (study II), using the 2-δδCT method. qPCR cycling conditions were as 
follows: 95C° / 10min; (45x) 95 C° / 30s; 60 C° / 20s; 72 C° / 30s.  
 
Table 6. Primers used in the qPCR analyses in the studies II and III in 5’-3’ orientation. 
Primers used in the qPCR analysis 
Gene Forward primer Reverse primer  
lin28b CTGGAACTTTGGAACGGAGG TGCGGACATTGAACCACTTG 
gnrh3 CACCAATACACATAGTGAATGAGG CCCGTCTGTCTGGAAATCTT 
kiss2 TATGCCAGACCCCAAACC AAGACTTGCGTTCGTCAGAA 
notch1a AGAGCCGGATTCAGCGGTC TTACAGGGACGTGGAGAACAAG 
ghrh GTGCTATGCTGCTTGTTACTATC ATACTTGACTGACGCTTTACATTG 
ss1 CCAAACTCCGCCAACTTC CTCCAGACGCACATCATC 
b-actin CGAGCAGGAGATGGGAACC CAACGGAAACGCTCATTGC 
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eif-1a CCAACTTCAACGCTCAGGTCA  CAAACTTGCAGGCGATGTGA  
esr1 CAGGACCAGCCCGATTCC TTAGGGTACATGGGTGAGAGTTTG 
esr2a CTCACAGCACGGACCCTAAAC GGTTGTCCATCCTCCCGAAAC 
ar CACTACGGAGCCCTCACTTGCGGA GCCCTGAACTGCTCCGACCTC 
pomca AGCTCAGTGTTGGGAAAACG GGTAGACGGGGGTTTCATCT 
oxt GGTGTCAGCCTTGGTGAATAAT GTTTGAGATGTAGCAGGCCG 
lhb GCAGAGACACTTACAACAGCC AAAACCAAGCTCTGGAGCAGCC 
fshb GATGCGTGTGCTTGTTCTGG ACTCGATCCATTGTCCAGCAT 
 
 
4.8 RNA-sequencing and processing of RNA-seq data (Study III) 
 
Quality and quantity of the extracted RNA samples were analyzed with 2100 Bioanalyzer RNA 
6000 Nano Kit (Agilent, Santa Clara, CA, USA) and Qubit RNA BR kit (Thermo Fisher Scientific, 
Waltham, MA, USA). For genomic DNA contamination measurement, Qubit DNA BR kit 
(Thermo Fisher Scientific, Waltham, MA, USA) was used. mRNA libraries were prepared from 
80 ng of extracted RNA with QuantSeq 3’ mRNA-Seq Library Prep Kit (Lexogen GmbH, Vienna, 
Austria) according to user guide version 015UG009V0221. ERCC RNA spike-in mix (Life 
Technologies, Carlsbad, CA, USA) was added as control to each sample according to 
manufacturer’s instructions. Libraries were quantified and pooled for sequencing using 2100 
Bioanalyzer DNA High Sensitivity Kit (Agilent, Santa Clara, CA, USA). Sequencing was 
performed with Illumina HiSeq2500 system in HiSeq high output mode using v4 chemistry 
(Illumina, San Diego, CA, USA). Read length for the paired-end run was 2x101 bp and target 
coverage 5 M reads for each library. 
 
Using Chipster analysis platform, the produced sequencing reads were preprocessed with 
FastX and PRINSEQ (191). The preprocessed reads were aligned to zebrafish genome build 
GRCz10 with TopHat2, and read count tables were produced by HTSeq. Differential 
expression (DE) analysis for RNAseq samples was performed using EdgeR in R 3.4.3 (192, 
193). Gene ontology (GO) pathway analyses of the RNA-seq data were performed with Gene 
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Set Enrichment Analysis (GSEA) and Gene Ontology enRIchment anaLysis and visuaLizAtion 
(GORILLA) tools in combination with REViGO (194, 195). 
4.9 Analysis of gene expression data from the GTEx database (Studies II & III) 
 
The Genotype-Tissue Expression (GTEx) Project is a resource providing gene expression and 
genotype data from hundreds of individuals and thousands of samples from various tissues 
(169). The data production and analysis procedures are available through the GTEx Portal 
(http://gtexportal.org) and described in detail in (196). 
 
In study II we queried the GTEx database to understand how the pubertal timing associated 
marker rs7759938 correlates with gene expression in the LIN28B locus. The GTEx eQTL 
results for pubertal timing and longitudinal growth associated SNPs rs7759938 and gene 
expression data [per sample gene Reads Per Kilobase Million (RPKM) values] for LIN28B and 
other genes in the locus used in this study were downloaded from the GTEx Portal. For study 
III, we queried the database to examine whether LIN28B expression correlates with the 
expression of key genes involved in the regulation of pubertal timing in the hypothalamus 
and the pituitary. 
 
The study II utilized the GTEx Analysis V6 release, dbGaP Accession phs000424.v6.p1, 
including tissue samples from 554 postmortem donors (187 females, 357 males; age range 
20–70). The GTEx data consisted of RNA sequencing data from 8555 tissue samples spanning 
53 unique tissue types, with genotype data available for up to 449 donors. For study III, we 
used the most recent  GTEx  release (v7), dbGaP Accession phs000424.v6.p1, including tissue 
samples from 714 postmortem donors (244 females, 470 males; age range 20–70), and RNA 
sequencing data from 11688 tissue samples spanning 53 unique tissue types. 
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4.10 In situ hybridization (Studies II and III) 
 
In situ hybridization was used to assess lin28b, kiss2 and gnrh3 expression in zebrafish 
embryos (Study II&IIII) larvae (Study II&III) and adult brain (Study III). For whole mount in situ 
hybridization (WISH), the embryos were dechorionated manually and treated with 0.03% 
phenylthiourea added in E3 medium to inhibit pigmentation. After sample collection, ISH 
was performed on 4% paraformaldehyde (PFA)-fixed embryos, 7-dpf dissected larvae brains 
and 210d old adult brains based on the protocol by Thisse & Thisse (197). Digoxigenin (DIG)-
labeled antisense and sense RNA probes for lin28b, kiss2 and gnrh3 had been generated 
using the DIG RNA labeling kit (Roche Diagnostics) based on full-length lin28b ORF construct 
cloned into p-GEM-t easy vector. Probe prehybridization and hybridization steps were 
conducted at 63 °C for all of the riboprobes. In situ hybridization signals were detected with 
sheep antidigoxigenin-AP Fab fragments (1:10,000, Roche Diagnostics). Color was developed 
with chromogen substrates NBT and BCIP (nitro bluetetrazolium and 5-bromo-4-chloro-3-
indolyl phosphate). The samples were transferred to glycerol before microscopy and 
imaging. 
 
4.11 Microscopy and imaging (Studies II and III) 
 
Images of embryos, and larval and adult brains showing location of lin28b, kiss2 and gnrh3 
mRNAs after ISH (studies II&III) were obtained with Leica DM IRB inverted microscope and a 
DFC 480 change-coupled device camera using 5x, 10x and 20x magnifications (Leica, Wetzlar 
Germany). Pictures of live 3d- (Study II), 5d- (Study III) and 6d-old (Study II) fish were taken 
with Leica DMi1, at 5x magnification, after the fish had been drugged with 0.02-0.03% 
tricaine. Fish length at 5d (Study III) and 6d (Study II) were measured from these images using 
the Leica Application Suite 4.5 software. The 2dpf fish shown in the supplementary data of 
the study II were imaged with NIKON Coolpix E4500, integrated to Leica MZFLIII. Cell 
counting (study III) was performed manually under inspection of the samples under the 
microscope, with the person counting the cells being blinded for the genotype information. 
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4.12 Genetic association study on LIN28B and serum testosterone levels 
(Study III) 
 
In study III, we utilised the UK biobank database containing over 500,000 individuals, aged 
between 40 and 69 at the time of recruitment (19). All participants signed a written informed 
consent for the UKBB study. We run an association analysis against serum testosterone levels 
for pubertal timing associated marker rs7759938, which has been shown to correlate with 
LIN28B expression levels at the hypothalamus and the pituitary.  Analysis was performed 
using linear mixed model association testing implemented in BOLT-LMM v2.3 software (198). 
Sex-specific log-transformed testosterone levels were adjusted for age and BMI, inverse 
normalised, and the analyses were run using 10 PCs as covariates. For the analysis including 
females, testosterone levels were further adjusted for menopausal status. The analyses 
included individuals from white British ancestry only, with testosterone levels between +/-
5SD from the population mean for each sex. 
 
4.13 Statistical analyses (Studies I, II and III) 
 
For study I, we ran a linear regression analyses using PLINK to assess whether pubertal timing 
markers rs7759938 and rs314279 would show evidence of association to adult body size and 
metabolic traits. Analyses were run separately for each participating cohort, assuming an 
additive genetic model and adjusting for subject age and sex. The two tested markers are 
only partially correlated, (r2 = 0.3, and D’ = 1), and we additionally evaluated the independent 
effect at each locus by including both SNPs into the regression model. To evaluate the 
collinearity of the two SNPs in the regression analyses, the variants’ variance inflation factor 
(VIF) was computed for each anthropometric trait with R (http://www.r-project.org/) 
version 2.12.2 (193). The meta-analysis was done with MetABEL 
(http://www.genabel.org/packages/MetABEL). Additionally, multiple linear regression 
analysis was performed to assess SNP by age and SNP by sex interactions for both markers. 
To account for multiple testing, we set a conservative significance threshold (p<0.005), based 
on Bonferroni-correction accounting for ten independent tests. 
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The data analysis for study II was performed with R version 3.0.2. The data from the qPCR 
analysis including 1- 5 d old fish (showing unequal variance between the groups) was 
analyzed with Welch ANOVA combined with a Games-Howell post-hoc test. The analysis of 
qPCR results from the 120d old fish brain was done with one-way ANOVA combined with 
post-hoc Tukey HSD. Fish length and head circumference at 6d was analyzed using the same 
methods. The juvenile growth data comparing WT and mRNA injected fish was assessed by 
a logistic regression model adjusting for fish age. Based on the data from Chen and Ge (70) 
and our own growth data, we made the assumption that the fish growth was approximately 
linear between two and four months (60-120d). We further performed time point and sex 
specific analyses using Welch two sample t-tests to assess the effect on growth in more 
detail. To compare the sex/egg ratios in adult fish and phenotype ratios in MO and mRNA 
injected embryos, we utilized Fisher's exact test and Bonferroni correction for multiple 
testing when necessary.  
In study II, a set of 20–25 embryos collected either at 1,2,3 or 5d and subjected to qPCR 
denotes an experimental unit. In the qPCR experiments using 120d fish, an experimental unit 
is a pooled sample consisting of 7-8 fish brain. Regarding the experiments assessing growth, 
either a well containing a single 6d larva, or a tank containing 7 to 21 juvenile fish was 
considered as an experimental unit. Fish growth was not tracked i.e. all the fish used in the 
study were measured only once. 
For study III, all statistical analyses were performed with R version 3.4.3, serving as a proxy 
to estimate the time that preparing the work for the thesis has taken. Fish genotype ratios 
from the heterozygote crosses were assessed with Chi-square test. Statistical analysis 
assessing fish size was made with ANOVA using post-hoc Tukey HSD. The qPCR results based 
on 130d fish brain and pituitaries were analysed using one-way ANOVA with post-hoc Tukey 
HSD.  
 
 
  
78 
 
5 Results and Discussion 
This chapter summarizes the results from the three original studies aiming to elucidate how 
LIN28B affects pubertal timing, growth and adult health. The results are based on 
combination of data sources, ranging from Finnish population cohorts to public gene 
expression data and to in-house created zebrafish models, and coming back to analysis of 
genetic data from subjects from the UK biobank. The variation in the data sources and the 
analysis methods characterizing this thesis reflects the complexity of the core problem we 
sought to unravel: how to proceed from genetic associations into understanding the related 
biology.  
The results have been divided into six sections, based on research aims of the original 
studies. The first section describes and elaborates the findings from the original study I, the 
second and third are based on study II, and in the 4th, 5th and 6th sections summarize the 
results from study III. Finally, I discuss the results collectively in the chapter 5.7. 
 
5.1 LIN28B associates with several features related to body 
composition in humans (Study I) 
 
The risk for many adult-onset complex diseases is known to correlate with growth patterns 
during fetal development and childhood. Epidemiologically, both early and late pubertal 
timing have been shown to correlate with the risk for many disease. These include 
cardiovascular disease and type 2 diabetes (T2D), which again are closely related to obesity. 
At the time of the first study, although the mice models had suggested Lin28-genes may 
regulate energy homeostasis and glucose metabolism, LIN28B had not been associated with 
metabolism and obesity in humans. Therefore, in the first study belonging to this thesis, we 
sought to assess whether the sequence variants in the LIN28B locus that had been associated 
with pubertal timing could be linked with body size and metabolic parameters in adult 
humans. To this end, we performed a candidate gene association study, utilizing data from 
the national FINRISK surveys including 26,635 Finnish adults that were subsequently 
genotyped for markers rs7759938 and rs314279.  
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5.1.1 LIN28B has pleiotropic effects on adult body size 
In study I, we linked pubertal timing-associate sequence variation near LIN28B with several 
dimensions of human body size.  First, the study replicated the previously shown associations 
with height.  In the combined analysis including both sexes, the pubertal timing increasing 
allele (C) of rs7759938 was robustly associated with increased height, (β=0.042, SE=0.009, 
P=2x10-6), corresponding roughly to 0.3 cm increase in height per allele.  Notably, the effect 
was stronger in females (Table 7). Moreover, when including the other marker (rs314279) in 
to the regression model, the same allele of rs7759938 was associated with increased waist-
to hip (WHR) ratio in males (β=0.043, SE=0.015, P=0.004).  
The effects of rs314279 seemed partially overlapping to rs7759938. Similarly to rs7759938, 
the pubertal timing increasing allele at rs314279 (C) was associated with height (β=0.039, 
SE=0.012, P=0.001). Additionally, in the analysis including both sexes the same allele was 
associated with increased weight and hip circumference (β=0.042, SE=0.013, P=0.001, and 
β=0.038, SE=0.012, P=0.003, respectively).  However, when conditioning with rs7759938, the 
association with height disappeared whereas the associations with weight and hip size 
stayed unchanged (Table 7). Although the associations were generally stronger in females, 
we did not find statistical evidence for sex-specific effects for the markers.  Yet, based on the 
observation that for many of the phenotypes the associations differed when conditioning 
with the other marker, our results suggest that there might exist more than one causal 
sequence variant in the LIN28B locus. 
The results thus suggested that LIN28B might have pleiotropic effects on human body size. 
First, we replicated the LIN28B association with height. The link between LIN28B and adult 
height was relatively strong already before the study, and the effect on height has since 
become confirmed in several other studies as well (14, 199, 200). The association with weight 
is likely explained by increased height: in fact when adding height as a covariate to the model, 
the associations with weight seem to disappear. Nonetheless, our study was the first to link 
LIN28B with increased hip circumference, an association that has been later confirmed in 
other GWAS studies (144). Although the WHR association with LIN28B has not been 
replicated in larger GWAS encompassing hundreds of thousands individuals (145, 200), these 
have suggested that the puberty delaying markers in the LIN28B locus may increase also 
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waist circumference. Interestingly, in these studies the effect on waist circumference 
however seems slightly bigger than the effect on hip size, hinting that the WHR association 
observed in our study might not be spurious. Remarkably, the direction of the effect seems 
to be always the same (i.e. an allele that delays puberty, likely due to increased LIN28B 
expression, always associates with an increase in a body size parameter). The associations of 
LIN28B in humans, including our study, thus closely resemble the results from various animal 
models where increased LIN28-expression has been consistently linked with larger body size, 
and proportional organ overgrowth (129).  
 
5.1.2 LIN28B does not affect serum lipids, but may contribute to 
insulin levels 
After assessing LIN28Bs contribution to body size, we wanted to evaluate whether the 
sequence variants rs7759938 and rs314279 might contribute to metabolic profiles in adults. 
~17,500 subjects from the FINRISK cohorts included into our study had serum lipid data 
available, whereas data for glucose and insulin levels were available from ~4000 subjects. 
We did not detect any significant associations between the sequence variants near LIN28B 
and lipid/lipoprotein levels. Captivatingly, the pubertal timing increasing allele C at rs314279, 
was linked with lower fasting insulin levels in males (β=-0.152, SE=0.051, P=0.003, Table 8). 
In theory this might reflect increased insulin sensitivity, like associated with LIN28A and 
LIN28B overexpression in mice (130). However, since insulin data was only available for a 
limited number of study subjects, and up to date the result has not been replicated, it needs 
to be interpreted with caution.  
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5.2 Transient dysregulation of lin28b causes permanent changes in the 
growth of zebrafish (Study II) 
After tackling LIN28Bs contributions to body size in humans, we wanted to develop a 
vertebrate model that would allow us to study the function of LIN28B in more detail. In study 
II, we concentrated on exploring whether lin28b dysregulation during embryogenesis might 
have consequences for zebrafish growth and development. Because of multiple reasons, we 
speculated that lin28b function during this period might be particularly significant. First, the 
gene is a stem cell factor, expressed in undifferentiated cells. In line with this concept, 
previous studies have suggested that lin28b expression is strongest during fetal development 
and downregulated in adults (105, 136, 201). Secondly, the primordia for all tissues, including 
the hypothalamus and the pituitary form already during embryogenesis.  Any genetic lesions 
that affect normal tissue development will likely have far-reaching consequences: for 
example failure in the migration of the GnRH neurons to the hypothalamus at this stage can 
lead to absence of puberty. Finally, supporting the hypothesis that embryogenesis partly sets 
the frames for adult health, epidemiological data have long implied that intrauterine insults 
at defined periods of development may have lasting effects on physiology and metabolism 
(202). 
Specifically, in study II we concentrated on examining how transient lin28b dysregulation 
affects zebrafish development. The precise questions we wanted to address with study II 
were 1) whether lin28b might contribute to the formation of tissues that regulate pubertal 
onset, and 2) whether embryonic dysregulation of the gene is enough to include changes in 
zebrafish growth. Hence, we mapped lin28b expression during the fetal stages and 
developed models to transiently dysregulate the gene. In these studies, we used anti-sense 
MO injections to knockdown the gene, synthetic mRNA injections to overexpress the gene, 
and combined injections of MO and mRNA to control for off-target effects of the MOs. The 
next sections will describe the results from these experiments, revealing how lin28b might 
contribute to the development of the hypothalamus and how embryonic lin28b 
overexpression can affect the adult size of the zebrafish.   
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5.2.1 lin28b expression peaks during embryogenesis and locates to HP 
axis in zebrafish larvae 
We first began by assessing the expression patterns of lin28b during embryogenesis.  Prior 
to our study it was already known that the LIN28 genes are prominently expressed during 
early embryonic development in vertebrates, becoming largely downregulated in adult 
organisms (105, 136, 201). Using in situ hybridization to localize lin28b expression in 
zebrafish embryos and larval brain, we observed how the expression pattern of the gene 
evolved rapidly, reflecting the extensive tissue remodeling taking place. Consistent with the 
presumed function of lin28-genes as factors expressed in undifferentiated cells, we saw how 
after ubiquitous expression during the embryogenesis, the expression of lin28b localized to 
specific organ primordia in zebrafish embryos at 2dpf (Figure 9B).  Importantly, the gene was 
also expressed in the brain during later development. At the time of embryonic to larval 
transition (3dpf), lin28b expression was clearly visible in the neuronal proliferation zone, but 
already at 7dpf the expression had become localized into a specific neuronal network that 
had projections to the HP axis (Figure 9C). Based on the expression pattern of the gene, it 
thus appeared that lin28b is widely expressed in many tissues, including neural tissues like 
the hypothalamus in early zebrafish development.  
 
Figure 9. Visualisation of lin28b expression by in situ hybridization. Images show lin28b mRNA expression 
localisation in zebrafish embryos at 1dpf (A) and 2dpf (B) and larval brain at 7dpf (C). At first, lin28b is expressed 
throughout the embryo, but quickly becomes localized to developing organ primordia. At 7dpf, the expression of 
lin28b is already restricted to a specific neuronal network including projections into the hypothalamus. Arrow in B) 
= pectoral fin bud, arrowhead = pharyngeal arches. Arrow in C) = hypothalamic/pituitary region.  Figure adapted 
from Leinonen et al. 2018 (203). 
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5.2.2 lin28b knockdown in zebrafish embryos  
The analysis of lin28b expression in zebrafish embryos and larvae suggested that interfering 
with lin28b expression could in theory have widespread consequences for fish growth and 
ontogeny. Next, we sought to study how transient knockdown of the gene would affect the 
development of zebrafish embryos. Potentially due to the infamous off-target effects of the 
MOs (discussed in section 2.4.7), injecting high doses of MO (3ng and 6ng) into zebrafish 
embryos appeared lethal. In contrast, the smallest MO doses induced no visible changes in 
most fish. After determining the dose-response curves for MO injections, we chose to work 
with doses that caused no gross morphological defects for the majority of the fish. With 
these doses (0.75ng and 1.5ng), most embryos injected with lin28b blocking MO remained 
WT-like, while some still showed distinct morphological phenotypes that could not be 
verified to result specifically from lin28b knockdown (Figure 10). These phenotypes included 
small heads and defects in body axis like curved tails that have been reported as potential 
side effects of MOs. Although we saw some evidence for lin28b knockdown reducing the size 
of the fish, because of the uncertainty to what extent this might be caused by off target 
effects we refrained from detailed study of the MO injected fish growth. Instead, we 
concentrated on studying the development of the hypothalamus, and aimed to control the 
findings by including a control group that received a combined dose of MO and synthetic 
lin28b mRNA to “rescue” the embryos.  
 
Figure 10. Representative images of 3-day old zebrafish, including fish injected with lin28b-blocking morpholino and 
synthetic lin28b mRNA. In all injected groups, most fish receiving injections as embryos showed no gross phenotypic 
abnormalities. Control injections shown here included phenol red and H20 only. Scale bars = 1 mm. 
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5.2.3 lin28b knockdown does not affect the development of Gnrh3 
neurons but may disturb the emergence of Kiss2 neurons  
To evaluate the potential consequences of lin28b knockdown on the development of the 
hypothalamus, we focused on studying the expression of gnrh3 and kiss2 in the morphants. 
These genes are homologous to human GnRH and KISS1, encoding for proteins which 
ultimately trigger pubertal onset.  During the embryogenesis the expression of gnrh3 is 
located at the olfactory placode, from where the gnrh3 expressing neurons are subsequently 
thought to migrate to the hypothalamus (31). Conflicting one of our primary hypotheses 
(that lin28b might affect the development of the Gnrh3 neurons), knocking out lin28b did 
not seem affect the expression of gnrh3 mRNA (Figure 11E). Interestingly, even in those 
embryos that showed mild morphological defects the gnrh3 expression localization and 
intensity appeared normal (Figure 11C).  We concluded that lin28b does not affect gnrh3 
expression during embryogenesis, ruling out the hypothesis that it specifically interferes with 
gnrh3 neuron migration and development. Contrasting the gnrh3 result, the expression of 
kiss2 however appeared downregulated in the MO injected embryos during the first 5 days 
of development in qPCR analysis (P=0.033). Our result therefore suggests that lin28b may 
contribute to the development of hypothalamic Kiss2 neurons. 
One critical feature distinguishes kiss2 from gnrh3 at this stage. Whereas the Gnrh3 neurons 
originate from the olfactory bulb, the Kiss2 neurons instead emerge in the hypothalamus, 
suggesting that lin28b may contribute specifically to hypothalamic development. The 
interpretation of the result still requires great care, especially in terms of whether these 
might be relevant for explaining the LIN28B association with pubertal timing. In fact, we do 
not know if LIN28Bs association with pubertal timing might be related to these changes at 
all. First, we characterized the effects of lin28bs during embryogenesis, and not at the time 
of pubertal onset or in adults. Secondly, our model does not mimic the expression changes 
seen in humans. Based on the GTEx data, each pubertal timing advancing allele is associated 
with a ~0.5 fold reduction in LIN28B expression, whereas in our zebrafish knockdown model 
we observed ~10 fold decrease in lin28b RNA by qPCR at 1dpf (Figures 8 and 11) (169). 
Moreover, the direction of the effect was somewhat counterintuitive: kiss2 repression at the 
time of puberty would likely cause a delay in pubertal onset based on the findings indicating 
that mutations in KISS1R associate with absent puberty. For these reasons, the finding 
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requires replication and further study in other models, and cautiously, we interpreted the 
result only as a sign that lin28b may contribute to the formation of the hypothalamus. 
Interestingly, the finding that lin28b knockdown may interfere with kiss2 expression 
nevertheless resembles the observation from the GTEx database that LIN28B expression 
correlates positively with KISS1 expression in the hypothalamus (study III). 
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Figure 11. A-E) Visualisation of gnrh3 and kiss2 expression in zebrafish embryos at 3dpf and qPCR results from 1-
5dpf zebrafish. A,B) = control fish,  C,D) = lin28b MO injected fish. Note the gnrh3 localization to olfactory bulb and 
kiss2 localization at the hypothalamus. Scale bars = 100 μm.  E) qPCR results from 3dpf zebrafish assessing the effect 
of lin28b up- and downregulation on selected genes during the first five days of development. Upper left panel: 
results show upregulation of lin28b expression upon synthetic lin28b mRNA injection (mRNA) (P = 0.00039) and 
downregulation of lin28b upon MO injection (MO) (P = 0.0042). Co-injection of lin28b mRNA and MO seems to 
result in partial rescue of lin28b expression (Rescue). Over the five-day period, the MO injected embryos showed 
reduced and mRNA injected embryos increased expression of lin28b compared to WT and. No significant differences 
were observed in the expression of notch1a and gnrh3, however kiss2 mRNA levels were significantly reduced in 
the MO group (P = 0.033, Welch ANOVA with Games-Howell post-hoc test, error bars = SEM). N = 12–20. Figure 
adapted from Leinonen et al. 2019. 
 
5.2.4 lin28b overexpression associates with increased fish growth and 
earlier sexual maturation 
Similarly to the MO experiments, injecting large doses (1μg) of synthetic lin28b mRNA caused 
lethality and malformations for zebrafish embryos. Contrastingly, a modest mRNA dose 
(125ng/embryo), causing ׽4-fold increase in lin28b expression in qPCR analysis caused no 
visible changes during embryogenesis. However, already by 6d post fertilization, the fish 
injected with synthetic lin28b mRNA appeared longer (P = 0.0011) than the control fish 
(Figure 12A).  Similarly, their head width was also increased (P = 0.00069), indicating that 
receiving an extra dose of lin28b mRNA may enhance zebrafish growth (Figure 12B). 
To see whether this effect on growth would persist to adulthood, the growth of the mRNA 
injected fish was tracked into adulthood. Remarkably, we observed that the mRNA injected 
fish remained on average longer than their siblings throughout juvenile development 
(P = 0.012, Figure 13A). The effect on growth was seen for fish of both sexes, although it 
appeared stronger in female zebrafish. Interestingly, the group receiving mRNA injections 
contained more sexually mature female fish (P=0.037) than the control group (Figure 13C). 
In study II we thus also reported the surprising finding that besides increasing growth, 
injection of synthetic lin28b mRNA may also advance the tempo of zebrafish growth.  
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Figure 12. lin28b overexpression increases zebrafish larval size. Both body length and head width were increased 
in the group receiving mRNA injections compared to controls at 6d. Reprinted with permission from Leinonen et al. 
2019.  
The first result, increased size after a single injection of lin28b mRNA into 1-cell stage eggs, 
was in some ways an expected finding. The direction of the effect fits the previous data 
suggesting that increased LIN28 expression is generally associated with bigger size both in 
humans and mice. Although we lack specific data about mRNA turnover rate, and its diffusion 
into different tissues, it is generally accepted that the injected mRNA stays potent during the 
first couple of days during development (186). More specifically, our result strongly suggests 
that particularly the embryonic lin28b expression might be crucial for determining the limits 
for vertebrate growth. The result is complimentary to a mice study that has suggested that 
fetal Lin28B knockout might be enough to cause reduced adult size, but Lin28b knockout 
after this stage has limited effects on mice size (131). In a wider context, these results 
highlight the importance of embryonic development in defining the limits for growth. 
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Figure 13. Transient lin28b overexpression causes permanent changes in zebrafish growth. A) The fish receiving 
an extra dose of lin28b mRNA as embryos remained longer than controls throughout the juvenile growth period. B 
Sex distribution of the fish C) The mRNA injected fish also showed tendency to mature earlier: the group receiving 
mRNA injections included more female fish that carried eggs at the end of the experiment.  Adapted from Leinonen 
et al. 2019. 
In contrast to the finding that lin28b overexpression increases fish size, the second finding 
that it also associated with earlier maturation of female zebrafish was rather unexpected. As 
opposed to our result, most other models including human data have consistently associated 
LIN28B overexpression with delayed maturation (10, 131). There is one notable exception, 
as one study has reported Lin28b knockdown to cause later puberty in male mice (133). 
Some plausible explanations for this rather surprising result do exist. First, in zebrafish sexual 
maturation is strongly dependent on body size (70), like observed in many other animals 
including humans (16, 50). Due to the size advantage gained by the zebrafish upon extra 
lin28b, the fish might have simply reached the critical body size required for sexual 
maturation earlier than the control fish. Similar mechanism might explain also the delay 
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puberty in lin28b knockout male mice that remained smaller than control mice (133). 
Secondly, since embryonic lin28b overexpression did not cause the expected pubertal delay, 
it may be that the strongest effects that LIN28B has on pubertal timing are caused by the 
gene’s actions later in life. In the discussion of the second study, we thus speculated that the 
molecular mechanism by which LIN28B may increase organismal size might be distinct from 
the mechanism that affects pubertal timing. 
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5.3 Gene expression data indicates a role for LIN28B at the HP-axis in 
humans (Study II) 
Gene expression data may provide vital clues for understanding the biology behind the 
GWAS associations. Particularly, it may provide answers for questions including 1) what is 
the causal gene in a locus, 2) what is the causal tissue and 3) what is the direction of the 
genetic effect i.e. does an allele linked with a trait either increase or decrease gene 
expression. Moreover, this type of data allows for detecting patterns and correlations 
between different genes, and thus may provide vital biological cues into the function of the 
genetic variants that have been associated with a trait. For example the GTEx database, 
containing genotypes and RNA expression data from postmortem human tissues provides 
an excellent starting point to study such questions (169). 
Because of the discoveries in C. elegans and the mice model linking LIN28A overexpression 
with delayed puberty and increased size, when planning the studies for this thesis we already 
had a good hunch that LIN28B might indeed be the causal gene in the GWAS locus. Similarly, 
we could be rather certain that these phenotypes would be related to increased LIN28B 
expression, although this had not been officially proven. However, many other questions 
remained completely unanswered, including what the causal tissues are and whether the 
expression of other genes in the locus might also contribute to growth and puberty. 
Additionally, we wanted explore whether the SNPs that associated with pubertal timing truly 
associated with increased LIN28B expression. To meet these aims, we utilized the GTEx 
database that helped us to gain vital insight into LIN28B function in adult humans.  
 
5.3.1 Pubertal timing associated SNPs affect LIN28B expression in the 
pituitary and the hypothalamus (Study II) 
We first concentrated on assessing the level of LIN28B expression across 53 adult tissues 
from the GTEx database. Although the relative LIN28B expression was generally very low 
across most tissues, there were a couple of exceptions to this pattern. Especially some brain 
subregions and the testis showed relatively high LIN28B expression compared to other 
tissues. Fascinatingly, out of all the examined brain regions (N = 14) hypothalamus and 
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pituitary appeared to have the highest expression levels for LIN28B. Among all tissues the 
expression peaked in the testis (Figure 14).  
Since the hypothalamus, the pituitary, and testes are all tissues which secrete hormones that 
are relevant for growth and puberty, we thought that LIN28B expression in these tissues 
might be relevant for explaining the GWAS associations. Therefore, we subsequently 
examined whether GWAS associated genetic variants in the LIN28B locus, including 
rs7759938 might correlate with LIN28B expression in these tissues. We found out that both 
in the hypothalamus and the pituitary the genotype at locus rs7759938 correlated 
significantly with LIN28B RNA expression (P = 0.0057 for the hypothalamus and 4.16e-05 for 
the pituitary).  LIN28B was also the only protein-coding gene whose expression was affected 
by these sequence variants, supporting it is likely the causal gene behind the GWAS signals.  
As expected, the same variant in rs7759938 (C) that had been linked with a delay in pubertal 
timing associated with increased LIN28B expression. Fascinatingly, neither rs7759938 nor 
other sequence variants were significantly related to LIN28B expression levels in the testis 
(P = 0.21). Collectively these results suggested that LIN28B is indeed the causal gene in the 
locus, and the hypothalamus and the pituitary might be the crucial tissues to study in order 
to understand the molecular biology behind the GWAS associations. 
 
 
Figure 14. LIN28B profiling in the GTEx database. In 
adult humans, LIN28B is expressed at low levels 
across all tissues with the peak expression in the 
testis, pituitary and hypothalamus (upper panel). 
The pubertal timing associated SNP rs7759938 as an 
eQTL in the pituitary and hypothalamus, (P = 0.0057 
for hypothalamus and 4.16e-05 for pituitary), but 
not in the testis (P = 0.21) (lower panel). The 
pubertal timing delaying allele (C) associates with 
increased LIN28B expression. The data shown as 
standardized mean expression, adjusted for 
principal components including sex and age. Figure 
reprinted with permission from Leinonen et al. 
2019(203)
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5.4 Insights into lin28b function from CRISPR-Cas9 KO models (Study 
III) 
In contrast to the transient lin28b dysregulation models used in study II, we next aimed to 
develop a model which would allow us to study the consequences of permanent lin28b KO 
on zebrafish development. Over the past couple of years prior to our study, CRISPR-Cas9 had 
emerged as a powerful new technology to knockout genes (183). We chose to apply this 
technology in study III, preparing CRISPR-Cas9 induced lin28b knockout (KO) models. 
Because of the relative simplicity and low cost of the technology, combined with the 
potential to induce sequence-specific genetic lesions, several different fields of molecular 
biology have rapidly adapted CRISPR-Cas9 as the gold standard method to study gene 
function. In our case, we were able to create two different lin28b KO zebrafish lines that 
made it possible for us to study the effects permanent lin28b KO then has on zebrafish 
growth and development (Figure 8 and section 4.6 in Methods). With our model, we 
specifically wanted to address two basic questions: 1) how does lin28b KO affect zebrafish 
growth and 2) whether lin28b KO fish would show changes in the development and the 
function of the HP axis, like suggested by our previous zebrafish model and the GTEx data 
(203). 
5.4.1 lin28b KO affects the timing and tempo of zebrafish growth 
Already before our third study, a consensus had emerged that LIN28 genes may regulate 
growth in various animal species ranging from humans to nematodes:  e. g. our previous 
study had suggested that transient, non-physiological lin28b overexpression can increase 
zebrafish body length. In the third study, we continued to assess lin28b effects on zebrafish 
size and growth by using the lin28b CRISPR-Cas9 KO fish we generated in-house. Upon 
superficial visual inspection, the lin28b KO fish appeared normal, and were born in the 
expected 1:2:1 genotypic ratio. The sex ratio of the fish was however notably biased: despite 
the genotype of the F2 fish, the great majority of the fish (~85-90%) were male. Hence, our 
results are largely based on data from male fish. After detecting no gross phenotypes in the 
lin28b KO fish upon visual inspection as embryos and larvae (Figure 15A, as opposed to the 
MO injections in study II), assessing the growth patterns of these fish became the logical 
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starting point for our study. Based on earlier data from humans, mice and zebrafish, our 
hypothesis was that lin28b KO zebrafish would remain smaller than control fish. We began 
by assessing lin28b KO zebrafish body size during the larval development. The development 
of the fish appeared generally normal, and neither head-to-tail length nor head 
circumference was significantly different in the KO zebrafish compared to heterozygous and 
wild-type siblings at 5dpf (N=201) (Figure 15C). On one hand the result was not surprising, 
since lin28b knockdown by MOs in study II also had non-significant effects on larval size when 
using non-toxic MO concentrations. Although the result did not complement the result from 
the mRNA injected fish showing increased growth already after six days of development, it 
therefore appears that downregulating lin28b during early development in zebrafish does 
not cause dramatic effects on larval size.  Yet, it is worth noting that the group in which lin28b 
expression had been downregulated (MO group in study II and KO group in study III) was in 
both studies on average the smallest, although the result did not reach statistical 
significance. Hence, it remains possible that lin28b has subtle effects on larval size, but these 
may be too small to have been detected under the current models and methods. 
 
 
Figure 15. Characteristics of lin28b KO fish during larval stages. A) Images of 5d old lin28b control (+/+) and KO (-
/-) larvae B) Full length lin28b mRNA expression in control vs lin28b KO RNA-Seq samples at 1d and 7d.  C) 
Comparison of lin28b KO and control zebrafish size at 5d. No significant size differences were observed at this stage 
(One-Way-ANOVA with post-hoc Tukey HSD, Error bars = SEM). 
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We next wanted to assess whether the knockouts exhibited similar alterations in the tempo 
and amplitude of longitudinal growth as previously reported for humans and mice, where 
lower LIN28B expression has been linked with smaller adult size. We designed an experiment 
where we tracked the growth of lin28b KO and control fish between 30d and 240d by 30d 
intervals (Figure 15A). In this experiment, the lin28b KO fish appeared on average smaller 
than other fish already by 30dpf. The KO fish remained smaller also at the end of the 
experiment, matching the results from humans and mice linking lower LIN28B expression 
with smaller adult size (131, 199).  
Besides the results showing that lin28b KO affected zebrafish size (growth amplitude), our 
model allowed us to observe also whether the growth proceeded in a similar fashion 
between the KO fish and the controls (growth tempo). Overall, zebrafish growth tempo 
shows extensive variation between individual fish (204). However, although the pubertal 
growth spurt has been thought to be somewhat specific to humans, just before sexual 
maturation, zebrafish show transient slowing of growth followed by a period of more rapid 
growth (9, 204, 205). We noticed that this transient peak in growth occurred earlier in lin28b 
KO zebrafish (Figure 16B). This closely resembles the finding from human data that 
individuals carrying genetic variants associated with lower LIN28B expression experience 
their pubertal growth spurt slightly earlier (9). Our data therefore suggests that in addition 
to affecting zebrafish size, lin28b may regulate also the tempo of fish growth in a similar 
manner as shown for humans. Remarkably, it appears that LIN28B-related genetic pathways 
represent a fundamental, evolutionarily conserved, mechanism to regulate vertebrate 
growth, despite the huge phenotypic diversity that exists for example between fish and 
mammals. 
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Figure 16. Characteristics and growth patterns of lin28b KO fish. A) Growth curves for lin28b KO and control fish. 
The KO fish remain smaller than control siblings, but the size difference temporarily vanishes around the time of 
sexual maturation (One-Way-ANOVA with post-hoc Tukey HSD, Error bars = SEM, *=P<0.05). B) Mean monthly 
growth by genotype. Around the period when the fish undergo sexual maturation the growth rate peaks 
transiently. The lin28b KO fish seem to undergo this transient peak in growth earlier than controls. 
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5.4.2 lin28b KO does not prevent, but may accelerate hypothalamic 
development in zebrafish larvae 
Many of the phenotypes associated with LIN28B such as growth, puberty and depression are 
related to HP axis function, and our earlier studies had revealed that the function of the gene 
may be especially relevant for the function and the development of the hypothalamus both 
in humans and zebrafish. Since the growth patterns of the lin28b KO fish supported the 
notion that the fish may be a reliable model to study the actions by which lin28b affects 
phenotypes detected in human GWAS, we turned our focus into lin28b function at the 
hypothalamic-pituitary (HP) axis.  
We first concentrated on evaluating whether lin28b KO fish might show visible changes in 
the structure and function of the HP axis. Since our previous model had suggested that lin28b 
knockdown may interfere with the development of the hypothalamus and specifically with 
emergence of the Kiss2 neurons, we begun by evaluating whether the knockout fish would 
show a reduced number, or differences in the organisation of kiss2 expressing cells at 3dpf. 
However, the location of kiss2 expression appeared similar in the KO and control zebrafish, 
and we observed no statistically significant differences in the number of kiss2 expressing 
cells between these fish (data not shown). Although the general trend was that there were 
less kiss2 cells in the KOs in the controls, we thus could not show that lin28b KO would block 
the development of the Kiss2 neurons. Potentially explaining the discrepancy between the 
current and our previous study (showing that MO induced lin28b downregulation may affect 
the development of the Kiss2 neurons), it is thought that gene loss by knockout may be quite 
well compensated by other genetic mechanisms in zebrafish. For example knocking out even 
key genes like gnrh3 and kiss2 does not lead to defects in hypothalamic development and 
function in zebrafish (178, 179, 206). 
Despite the result that lin28b may not be essential for hypothalamic development in 
zebrafish, we continued to assess links between the gene and the HP axis. As by 7dpf the 
expression of lin28b in the zebrafish brain is largely restricted to specif neuronal networks 
including the hypothalamus and the pituitary, we next analysed RNA-seq data from 7dpf 
zebrafish concentrating on selected hormonal genes expressed from the HP axis. Overall, the 
expression patterns for most genes between the lin28b KO and control larvae did not differ 
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dramatically, but when analysing the expression of all the studied HP axis genes together, 
we noticed their expression was generally upregulated in the KO zebrafish at 7dpf (p<0.05). 
Out of individual genes which were analysed in the study (encoding for established 
hypothalamic and pituitary hormones that were expressed in high enough quantities to be 
observed in the RNA-seq analysis), we observed nominally significant upregulation of chrb 
and oxt (p<0.005). Moreover, in the pathway analysis of the RNA-seq data, we noted that 
the KO fish showed upregulation of genes that respond to estrogen signalling. During normal 
zebrafish development, the relative expression of hormonal genes steadily increases during 
the larval stages (203, 207). Altogether, the results suggest that hormonal development may 
be slightly advanced in the KO zebrafish at this stage, resonating with an idea that lin28b KO 
may speed up tissue maturation.  
 
5.4.3 lin28b KO may affect ESR1 expression after sexual maturation 
In study III, the larval RNA-seq data encouraged checking whether we could detect changes 
in the expression of HP axis genes in the lin28b KO zebrafish. We first concentrated on 
assessing the expression levels of selected HP-axis genes by qPCR in 130dpf KO zebrafish, 
including zebrafish homologues for known puberty genes such as gnrh3, kiss2, lhb and fshb. 
Mimicking the human results from the GTEx database, esr1 expression appeared 
downregulated in the KO fish brain compared to control fish (p<0.05) at this stage. However, 
no other genes were shown to be either up- or downregulated in the KO fish, including kiss2 
and gnrh3 (Figure 17B). Similarly to the results from the larval fish, we observed no 
consistent differences in the location or staining intensity of kiss2 and gnrh3 expressing cells 
between the KOs and controls, whereas the staining pattern between individual samples in 
each group varied showed some variation (Figure 17C). Despite the hints that LIN28B might 
affect the development and function of the HP axis, excluding the potential esr1 
downregulation, we thus failed to see any dramatic changes in the kiss2-gnrh3-
gonadotrophe-pathway in our lin28b KO fish after pubertal maturation. However, the esr1 
finding provided further suggestion that estrogen-related signaling might differ between the 
knockouts and the control fish. 
  
100 
 
5.4.4 RNA-Seq analysis links lin28b KO with upregulation of 
mitochondrial pathways in zebrafish embryos and larvae 
As LIN28B has been associated with a wide variety of traits, besides tackling the question 
whether lin28b may play a role in the regulation of the HP axis we were also interested in 
screening for global changes lin28b KO might induce to zebrafish RNA transcriptome. Based 
on our earlier work we knew that the relative lin28b expression peaks during embryogenesis, 
and therefore we decided to concentrate on analyzing gene expression during embryonic 
and larval development.  To this end, we collected samples from altogether 163 lin28b -/- 
and +/+ fish at 1dpf and 7dpf. The samples were pooled and subjected to 3’ end RNA 
sequencing which then allowed for differential expression (DE) analyses. 
 
Figure 17. Characterization of HP axis development in 130dpf lin28b KO fish.  A) images of 130dpf lin28b KO and 
control fish, also at this stage, the KO fish appeared perfectly normal and healthy, showing no distinct phenotypes 
when compared to the control fish. B) qPCR results from 130dpf fish showing lower esr1 expression in the KO fish, 
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though in general HP axis genes show within group variation that exceeds the variation between groups. C) 
Visualisation of kiss2 and gnrh3 expression localization in the 210dpf zebrafish brain. Localization between the KO 
and control fish appears similar, although the number of stained cells varies between individual samples.  
Owing to relatively small sample size (N=4-6 biological replicates per group), and large 
number of genes studied (9304-11,292) only a couple of individual transcripts passed the 
false discovery rate (FDR) threshold (<0.1) in the analysis (Table 9). We thereafter focused 
on identifying transcriptomic pathways that were altered in lin28b KO fish compared to 
controls. Besides the estrogen signaling finding that was discussed in section 5.4.2, another 
major theme emerged from the pathway analysis of 1dpf and 7dpf fish: lin28b KO zebrafish 
showed consistently increased expression of mitochondrial genes during the first days of 
development (Figure 18). Remarkably, the result supports the earlier findings suggesting 
that lower LIN28 activity promotes aerobic (mitochondrial) metabolism at the expense of 
glycolytic  pathways: for example in murine pluripotent stem cell models loss of LIN28 
function has been associated with increase mitochondrial activity and prolonged 
mitochondrial mRNA half-lives (116).
We speculate that since mitochondrial metabolism is the preferred means of energy 
production in differentiated cells, theoretically, the result might be a reflection of lin28b KO 
zebrafish having less dividing, and more differentiated cells than controls (208, 209). This 
hypothesis fits the concept of lin28b acting as a gene that keeps cells in proliferating state. 
As suggested in the case of LIN28A and mice, eventually such tendency to prefer 
mitochondrial metabolism might lead to a reduction of the total number of cells in the 
organism, causing smaller adult size (129). Overall, the GO analyses of the global RNA-seq 
data thus hint that lin28b may contribute to the selection of cellular metabolic programs at 
the whole organism level in zebrafish larvae. 
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Figure 18. Summary of the GORILLA results visualized by REVIGO, indicating how top 1000 DE genes in the lin28b 
KO fish have been enriched for genes related to the function of the mitochondria. 
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5.5 LIN28B expression correlates with the expression of several HP axis 
genes (Study III) 
Besides relying on lin28b KO zebrafish model, we continued to utilize the publicly available 
databases in study III. After showing how the pubertal timing associated sequence variation 
affects LIN28B expression at the HP axis in study II, we carried on mining the GTEx database, 
aiming to characterize whether LIN28B expression would correlate with the expression of 
selected HP axis genes (Figure 19).  These genes included ESR1, ESR2, AR, KISS1, KISS1R and 
GNRH1, which are part of the hormonal loop that regulates sexual maturation. 
Unexpectedly, we observed that in adult humans, lower LIN28B expression seemingly 
correlated with lower expression of the aforementioned genes (P<8e-10 to <3e-19) in the 
hypothalamus. Surprisingly, lower LIN28B expression (associating with earlier pubertal 
onset) thus in fact seemed to correlate with lower expression of the GNRH1 and KISS1, which 
are known to promote sexual maturation. As KISS1 and GNRH1 are thought to stimulate 
pituitary gonadotropin secretion, we expected that lower LIN28B levels might correlate with 
lower lutenizing hormone (LH) and follicle-stimulating hormone (FSH) mRNA levels in the 
pituitary. Contrasting this hypothesis, LH and FSH levels appeared uncorrelated with LIN28B 
expression in the GTEx dataset (Figure 19).   
Although LIN28B levels did not correlate with gonadotropin mRNAs, the expression of 
proopiomelanocortin (POMC) mRNA showed a strong positive correlation with LIN28B 
expression in the pituitary (P<3e-17, Figure 19). Remarkably, POMC mRNA, which is a 
precursor for several peptides was both among the top 3 most expressed genes in the 
pituitary as well as among top 20 genes whose expression correlates with LIN28B (169). The 
peptides that are made based on POMC include b-endorphin, melanin, and 
adrenocorticotrophic hormone (ACTH) that regulate various physiological processes in the 
human body including appetite and glucocorticoid secretion. The strong association with 
POMC suggests that LIN28B may indeed contribute to the foundation of hormonal dynamics 
at the HP axis.  
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Figure 19. LIN28B expression correlations with selected HP axis genes from the GTEx database.  In the 
hypothalamus, the expression of LIN28B correlates strongly with the expression of genes that are known to promote 
pubertal onset, but these correlations are not reflected in the expression of  their targets LH and FSH. Conversely, 
pituitary POMC expression correlates significantly with LIN28B expression. P-value in parentheses reflects how likely 
another gene that has similar expression levels to the studied gene has as strong or stronger correlation with 
LIN28B). 
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5.6 LIN28B affects serum testosterone levels (Study III) 
Collectively, the available GWAS data from humans, and the results from our zebrafish 
models and the GTEx database suggest that LIN28B may affect the expression of hormonal 
genes at the HP axis in an unexpected manner. Therefore, we finally wanted to explore the 
possibility that the gene might contribute to serum hormone levels in adults. Previously, we 
have shown how pubertal timing delaying allele (C) for rs7759938 from the LIN28B locus 
associates with higher LIN28B expression in the hypothalamus and the pituitary in adult 
humans. To finalize study III, we performed an association analysis to detect whether the 
same marker would affect serum testosterone levels in the UKBB database. Remarkably, we 
observed that the C allele at rs7759938 associates robustly with lower serum testosterone 
levels in adult humans (N=351,062, P= 9.2e-16, Table 10).  The association was especially 
clear for males (P=2.5E-37) whereas it did not reach genome-wide significance (P<5e-8) in 
females (P=0.0067).  In study III we thus provided for the first time evidence that the variants 
associated with higher LIN28B expression associate also with lower serum testosterone 
levels in adult humans. 
Table 10. Association of rs7759938 with serum testosterone levels in UKBB. A1=effect 
allele, A2=other allele, EAF=effect allele frequency. 
 SNP N Chr Pos A1/A2 EAF Beta SE P 
Males rs7759938 176212 6 105378954 C/T 0.32 -0.044 0.003 1.5E-37 
Females rs7759938 174850 6 105378954 C/T 0.32 -0.010 0.003 0.0067 
M+F Combined rs7759938 351062 6 105378954 C/T 0.32 -0.020 0.002 9.2e-16 
 
 
 
 
 
 
 
 
  
107 
 
 
5.7 Discussion: insights in to the function of LIN28B 
The previous chapters describe and summarize the key findings from the original studies I-
III forming the basis of this thesis. Each of the original studies has provided novel information 
about the function of LIN28B. Although we still lack a definite answers on for example from 
where does the pubertal timing association come from, collectively these studies have 
increased our understanding of the potential molecular mechanisms by which LIN28B may 
affect the formation of complex traits. In the beginning of this thesis project, we had set 
three specific aims. The aims included 1) studying how LIN28B affects body size and 
metabolism in humans, 2) in which way and in which tissues do the sequence variants in the 
LIN28B region affect the gene’s expression and 3) how does manipulating lin28b expression 
in zebrafish affect the development and growth of the fish. On the way, the projects evolved 
to encompass also studying LIN28B’s potential contribution to hormonal signaling in 
vertebrates. Below I discuss whether these aims were accomplished, and what additional 
implications these results may have. 
 
5.7.1 LIN28B has pleiotropic effects on body size but has little effect 
on serum metabolites in adult humans 
The aim 1, studying how LIN28B affects body size and metabolism in humans, was mostly 
addressed in study I. Overall, the results from study I, encompassing ~26,000 Finnish 
individuals suggested that LIN28B has potential to contribute to body size and shape in more 
complex ways than appreciated at the time. We associated variants rs7759938 and 
rs314279, linked with delayed pubertal timing, with increased height, weight, hip size and 
WHR. Since then, studies in larger datasets have provided more evidence that sequence 
variants in the LIN28B region indeed affect human body size in complex ways (144, 145). 
Remarkably, the studies by others and us have also shown how homologous LIN28 genes 
may affect organism size also in complex ways in other vertebrates like zebrafish and mice, 
strongly supporting the notion that LIN28 genes participate into evolutionarily conserved 
genetic pathways that regulate development and growth in vertebrates. For example, it 
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appears that zebrafish with modified lin28b expression exhibit alterations in body size. This 
and the potential mechanisms behind the body size associations will be further discussed 
especially in chapter 5.7.3, addressing the results from the zebrafish models. 
Although LIN28B contribution to human body size therefore appears robust, the results from 
our study did not show evidence for LIN28B significantly affecting lipid nor T2D related 
metabolite levels in adults, although we detected a nominal association with rs314279 and 
insulin levels in males. Many of the body size associations from our study have been later 
replicated in larger datasets, but evidence for LIN28B affecting lipids and T2D related traits 
is still lacking despite some considerably larger studies have been conducted (19). 
Considering the reports that LIN28B expression may affect the choice of metabolic pathways 
in cell models, mice and apparently in zebrafish, this is slightly surprising (116, 131). Notably, 
however, for example the mice models addressing Lin28 effects on glucose metabolism are 
based on leaky overexpression or complete knockout of LIN28 function. Contrastingly, under 
normal conditions LIN28B expression peaks during embryogenesis, and becomes restricted 
to specific cellular structures in mature tissues (203). Therefore, we can speculate that any 
effects LIN28B might have on metabolism would be restricted to the early developmental 
period, and that other genetic and environmental factors are more likely to affect serum 
metabolite levels in adults.  
One aspect that was briefly touched in study I, namely the existence of more than one causal 
sequence variant in the LIN28B locus has received little attention beyond our studies, and 
should be confirmed in larger datasets, ideally based on different ethnic groups. However, 
up to date most other published studies including large number of subjects have reported 
that the most prominent genetic effect in the LIN28B region is tagged by a haplotype that 
that contains the variant rs7759938 (Table 2). Although none of these studies have provided 
evidence for any of non-coding variants at the LIN28B region for being truly causal, at the 
same time no protein coding variants in the LIN28B gene (that remain extremely rare) have 
been shown to have phenotypic effects.  The challenge to pinpoint the actual causal 
variant(s) in the LIN28B locus thus still exists. However, most likely the main genetic effect 
underlying the GWAS signals is based on a variant affecting LIN28B expression: in study II we 
showed how different alleles for rs7759938 correlate with differences in the amount of 
LIN28B mRNA transcript in the HP axis (discussed in more detail in the chapter 5.7.2). 
  
109 
 
Besides offering evidence of the pleiotropic actions of LIN28B, study I highlights a couple 
more points relating to studying GWAS loci. First, it seems that despite not reaching 
“genome-wide-significant” P-values, even weaker associations may reflect true biological 
effects. Especially, this is likely true if there exists a solid biological hypothesis behind the 
association, like in the case of LIN28B and hip circumference (based on mice studies, LIN28 
genes appeared to lead to a general increase in body size).  The contribution of such weak 
genetic effects on complex traits has been extensively theorized and also shown to apply in 
many cases (86). On the other hand, for many phenotypes in our dataset the effect size 
estimates showed wide confidence intervals and varied between markers and depending on 
sex. Whereas some of the associations we detected have been replicated, others have not. 
For example, after our study no association with LIN28B and insulin levels has come up, even 
the number of individuals in insulin GWAS has risen to hundreds of thousands in the largest 
studies (19). Altogether, this could be seen as a demonstration of the fact that when dealing 
with subtle genetic effects, a relatively large study like ours (encompassing ~4000-26,000 
subjects depending on the phenotype) has power to detect some effects, but may still 
remain sensitive for statistical fluctuation or uncontrolled demographic and environmental 
effects. Notably, the study I also lacks formal control of potential population stratification 
for example by including genetic principal components (PCs) in the analysis as covariates, 
which in theory may lead to spurious associations. However, in general we saw little 
evidence for the association patterns differing markedly between different geographical 
regions, or collection years of the FINRISK studies (data not shown). 
 
5.7.2 Gene expression data supports LIN28B as the likely causal gene 
in the locus and links the gene with the regulation of the HPG axis 
The second aim of this thesis, assessing how the sequence variants in the LIN28B locus affect 
gene expression and whether this might have consequences on the function of the HPG axis 
was addressed in studies II and III. To this end, we leveraged the gene expression data from 
the GTEx database, containing tissue specific gene expression data from adult humans in 
both studies. In study II, reporting the results for SNP rs7759938 we showed how the 
pubertal timing associated genetic variation likely affects LIN28B expression mainly in the HP 
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axis of adult humans. Our study was the first to show a direct link between a GWAS SNP and 
LIN28B mRNA levels, suggesting that understanding LIN28B function at the HP axis may be 
critical for understanding the biology behind the GWAS associations. Importantly, although 
previous animal models had strongly suggested that LIN28B might be the causal gene in the 
locus (instead of the other genes that reside near the GWAS SNPs) the study was the first 
one to show that LIN28B is the only protein coding gene whose expression if affected by 
these SNPs. The result thus strengthens the concept of LIN28B being the truly causal gene in 
the locus. The most up to date versions of the GTEx database, including over 700 individual 
donors, have only reinforced the reported association between pubertal timing markers and 
LIN28B expression (169). Yet, it is worth recalling that these results from the GTEx project do 
not necessarily reflect the transcriptional milieu that is present around the timing of puberty 
in healthy population, as the database is mostly based on relatively old (median age >50), 
deceased individuals. However, we can speculate that these changes in LIN28B expression 
tagged by these SNPs indeed remain consistent throughout human life-course, and thus 
might underlie some of the genetic association results. 
In study III we found out how LIN28B expression correlates positively with the expression of 
several hormonal genes in the HP axis. This was somewhat unexpected, since for example 
the activity of KISS1 and GNRH1 is known to promote sexual maturation – which is a 
phenotype related to lower LIN28B expression. The parallel observation that decreased 
LIN28B expression did not correlate with decreased gonadotrophin mRNA levels in the 
pituitary anyhow points towards an interesting hypothesis that might explain why LIN28B 
associated with traits like puberty and 2D4D finger length ratio (Figure 20). Potentially, with 
lower LIN28B expression the pituitary might become “calibrated” to require less 
hypothalamic stimulation to induce gonadotrophin secretion. In theory such an effect might 
be driven for example by LIN28B affecting the cellular structure and organisation of the 
hypothalamus/pituitary, instead of directly controlling the expression of individual hormonal 
genes. This would offer an intriguing mechanistic explanation for the advanced onset of 
puberty associated with lower LIN28B expression: the individuals that express less LIN28B 
would be poised to start gonadotrophin secretion with less hypothalamic stimuli, i.e. lower 
GnRH pulse would be required for pubertal onset. On the other hand, by reducing the 
hypothalamic ESR1 and AR expression, the data allows also speculation that LIN28B might 
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simply modify the sensitivity of the HP-axis to negative sex steroid feedback, causing an 
increase in the amount of circulating sex steroids. However, these mechanisms remain 
speculative and require further study, and for example do not overrule the hypothesis that 
LIN28B effects on pubertal timing might be related simply to somatic maturation of the HP 
axis (134). Nevertheless, these hypotheses resonate well with the result that the same SNPs 
that increase LIN28B expression also decrease testosterone levels in adult humans, in both 
sexes (section 5.6, Study III). The theories would go together also with the observation that 
the timing of puberty is similarly altered in males and females, supporting the notion that 
the change in the timing is driven by a central mechanism affecting both sexes (10, 210).  
 
Figure 20. Schematic description of a speculative mechanism whereby LIN28B might affect the hormonal dynamics 
at the HP axis based on GTEx expression data and GWAS associations. 
Another observation from the GTEx data in study III (higher LIN28B expression associates 
with higher ESR1 expression) is also particularly interesting for several reasons. First, the 
observation that estrogen signalling may be altered in the HP axis raises the possibility that 
the effects LIN28B has on sex steroids are not be limited to testosterone, but may also 
involve estrogen and estradiol. Additionally, this reflects some of the findings from the 
zebrafish models. As discussed in the section 5.7.3, estrogen signalling appeared affected 
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also in the lin28b KO fish, supporting the potential relevance of LIN28B to the regulation of 
sex steroid pathways seen in human data. Secondly, both ESR1 and LIN28B have been shown 
to affect similar traits. Mice studies have shown how estrogen receptor alpha (ESRα) 
signalling in kisspeptin neurons regulates puberty: the mice in which ESRα has been knocked 
out in KISS neurons show advanced pubertal development (211).  Moreover, ERα knockout 
in medial basal hypothalamus has been shown to lead to increased bone mineral density 
(BMD) in female mice. Fascinatingly, the genetic variants that lower LIN28B expression have 
been associated with both traits, supporting the idea that the ESR1s finding might be 
particularly important for understanding LIN28B-related biology. Nonetheless, the 
regulation of pubertal onset and progress by estrogen signalling is notoriously complex, 
including both suppressive and activating functions and multiple receptors, and hence the 
finding should be carefully followed up (25, 211).  
Finally, based on the GTEx data an interesting observation was the strong positive correlation 
between POMC and LIN28B expression in the pituitary. Captivatingly, increased POMC 
activity has been linked to lower prenatal testosterone exposure, fitting together with the 
observation that higher LIN28B expression associates with lower testosterone levels (212). 
Lower prenatal testosterone in turn is known to be closely related to higher (feminized) 
2D4D-ratio, one of the phenotypes that has been associated with increased LIN28B 
expression (213). Additionally, one of the peptides made based on POMC mRNA is b-
endorphin, which binds opioid receptors and participates to regulation of stress response, 
and thus might be relevant in terms of LIN28B association with depression and potentially 
also insomnia (17). In essence, the gene expression data from the GTEx thus indicates that 
LIN28B expression might actually modify the hormonal dynamics at the HP axis in complex 
and previously unappreciated ways. Overall, the results from the database have provided 
critical insight into the possible mechanisms that might underlie LIN28B associations with 
pubertal timing and other complex traits.  
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5.7.3 Zebrafish models suggest LIN28B affects growth in an 
evolutionarily conserved manner, and hint at possible molecular 
mechanisms behind the genetic associations 
Besides using several different types of human data, the original studies of this thesis have 
largely revolved around various zebrafish models. For aim three, to study lin28b function in 
the regulation of vertebrate growth, we generated transient lin28b 
knockdown/overexpression models in study II, and permanent lin28b KO models in study III.  
Taken together, the results from the studies support the concept that LIN28-genes have 
potential to affect vertebrate growth in a complex manner. Remarkably, it appears that the 
genetic pathways that involve LIN28B have the potential to define the patterns and limits for 
vertebrate growth already during embryogenesis. In study II we had three main findings: 1) 
Increasing lin28b expression transiently by synthetic mRNA injections during embryogenesis 
results in permanent increase in zebrafish size 2) lin28b may have potential to contribute to 
development of the zebrafish hypothalamus and 3) the mechanisms causing LIN28B to 
associate with body size and pubertal timing might be distinct. Considering also the data 
from mice, and the established expression pattern of LIN28-genes, the results from study II 
strengthen the concept that the effects these genes have on growth may be determined 
relatively early during development, when the expression of the genes is ubiquitous and 
strong compared to adult tissues. The result is supported by the finding in mice that fetal 
actions of Lin28B are crucial for growth (131).  
Arguably, the studies in zebrafish support the concept that the genetic effects by which 
LIN28B affects body size may be distinct from the effects affecting pubertal timing. 
Importantly, these may be separated in time: we now think LIN28Bs effect on growth 
potential may be largely determined during the fetal stages, but the effect on pubertal timing 
might occur later during development. First, in study II transient overexpression of lin28b 
during embryogenesis increased zebrafish size as expected, but had rather unanticipated 
effects on the sexual development of the female fish. In study II, embryonic lin28b 
overexpression causing bigger body size also advanced sexual maturation, which we 
interpreted as a secondary consequence of the bigger body size, and not as a direct lin28b 
effect. Contrastingly, in study III assessing the consequences of permanent lin28b knockout 
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we observed both reduced fish growth and – using growth velocity as a proxy – also the 
anticipated effect (advancement) on the timing of sexual maturation. 
To offer insight into the genetic mechanisms regulated by lin28b during early development 
(potentially affecting fish growth), in study III we performed a global RNA-seq analysis on 
1dpf and 7dpf fish. Remarkably, it appeared that mitochondrial metabolism was enhanced 
in the lin28b KOs during these early stages, which in theory might be mechanistically related 
to the smaller size of the KO fish. We concluded that, like speculated in the case of Lin28A 
and mice, the effect LIN28 genes have on growth might be related to the regulation of overall 
number of cells across tissues. This in turn, might be achieved by LIN28B’s contribution to 
cellular metabolism: suppression of mitochondrial OXPHOS at the expense of glycolytic 
pathways, (that is known to be the preferred metabolic choice of dividing cells) (116, 208). 
Overall these results from zebrafish thus appear to strengthen the concept that LIN28-genes 
have potential to affect cellular metabolism during early development. Unfortunately, we 
lacked models for addressing whether these effects are indeed restricted to early 
development in zebrafish. 
Besides addressing phenotypes linked with cellular growth, many of the phenotypes 
associated with LIN28B are subject to hormonal regulation and the function of the HPG axis. 
Therefore, with our models we additionally wanted to specifically assess whether tinkering 
with lin28b expression might have consequences on the function of the hypothalamus and 
the pituitary in zebrafish. The results based on our models are partly conflicting: in study II 
we observed that knocking down lin28b might delay the development of the hypothalamus 
(reflected by suppression of kiss2 expression), but in lin28b KO fish the development of the 
axis appeared relatively normal, or rather more advanced.  Based on these models it thus 
appears that lin28b may not be essential for development of the HP axis, but may indeed 
have potential to affect its function. Partly, the conflicting results between the two models 
might be related to the fundamental differences that exist between them: compared to gene 
knockdown by MO used in study II, which is notoriously prone to causing off-target effects, 
gene KO strategy used in study III is contrastingly notoriously well compensated in zebrafish 
(179, 184).  
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Suggesting that lin28b function might be relevant for the HP axis function, we however 
observed that hormonal signaling might be altered also in lin28b KO fish. Already at 7dpf, 
when lin28b expression in largely restricted to the hypothalamus and the pituitary, GO 
pathway analyses suggested that the KO fish show upregulation of genes that respond to 
estrogen signaling. Similarly, at 130dpf (around the timing of sexual maturation) the main 
estrogen receptor (esr1) appeared downregulated in the KO brain. The findings thus support 
the notion that sex steroid signaling might be upregulated in the KO fish. They also resonate 
with the data from the GTEx, which links sequence variants with lower LIN28B expression to 
downregulation of ESR1 in the hypothalamus in humans. Therefore, simultaneously 
considering the testosterone finding discussed below in section 5.7.4, it currently appears 
likely that the contribution of LIN28B to hormonal regulation may be crucial to explain why 
the gene has been associated with many traits such as pubertal timing, 2D4D finger length 
ratios and BMD. 
Overall, the results from lin28b zebrafish models have aided in creating a picture about the 
significance of LIN28B for vertebrate development, and have partly revealed potential 
molecular mechanisms whereby the gene might affect several phenotypes. In summary, the 
results indicate that LIN28B related genetic mechanisms regulate the timing and tempo of 
vertebrate growth in an evolutionary conserved manner. Importantly, based on the transient 
overexpression models, it seems that LIN28B related genetic pathways represent a set of 
genetic mechanisms, which – if perturbed during embryogenesis due to any reason – have 
the potential to impact the subsequent developmental framework over an organism's life 
course. Moreover, based on these zebrafish models, is appears possible that the pleiotropy 
of LIN28B can be partly explained by different actions of the gene at different time points in 
development. It appears likely that lin28b’s effects on cellular metabolism during the fetal 
stages may directly affect the regulation of vertebrate body size, whereas the potential 
effects the gene has on hormonal signaling later in life might be more relevant for 
phenotypes like puberty and sexual maturation.  
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 5.7.4 Could the testosterone association help to explain why LIN28B associates 
with so many phenotypes? 
Over the course of this thesis, it has become increasingly apparent that LIN28B and its 
homologues in other species may have potential to contribute to hormonal dynamics in 
vertebrates. Remarkably, the finding that the SNPs linked with higher LIN28B expression 
associate also with lower circulating testosterone levels in humans might be crucial in terms 
of answering the question that essentially motivated this project: how does LIN28B affect 
pubertal timing (and many other traits that have been since associated with the gene). Over 
the past years, many data sources have offered indirect evidence that LIN28B might affect 
the hormonal milieu for an individual. First, many of the traits that have been associated 
with LIN28B are directly regulated by hormones. For example pubertal timing depends on 
the acquisition of hypothalamic GnRH pulse that translates to gonadotrophin secretion, 
triggering sex steroid activity that is ultimately responsible for the physiological changes 
associated with puberty. Already before the testosterone association result, based on the 
GTEx data, we had speculated that the positive correlation with LIN28B and hypothalamic 
gene expression (discussed in results section 5.5) might reflect changes in circulating sex 
steroid levels, a hypothesis that has now gotten some further support. Notably, although the 
effect was stronger in males, we saw evidence of LIN28B affecting testosterone levels in both 
sexes. Combining this observation with the result from study II (the SNPs at the LIN28B 
region affect LIN28B expression primarily in the hypothalamus and pituitary and not in the 
testis), we have grounds to speculate that the gene’s effect on testosterone levels might 
actually be set at the HP axis. Like speculated in the chapter 5.7.2, this might result from 
changes in gonadotropin secretion or HP axis response to negative steroid feedback. This 
again raises the possibility that the effect is not limited to male hormone testosterone: 
LIN28B might also affect estrogen levels, although this remains to be studied.  
Besides puberty, many other traits linked with LIN28B have shown links to sex steroids. The 
gene has been associated with traits like 2D4D finger length ratio and bone mineral density, 
which have both been shown to be regulated by testosterone (213, 214). As in the case of 
puberty, the direction of the effect is biologically sensible i.e. SNPs associating with lower 
LIN28B expression (and thus higher testosterone levels) associate also with masculinized 
2D4D ratio and increased BMD, traits which have been directly shown to be affected by the 
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hormone (214, 215).  Although we lack any direct causal evidence that LIN28B’s effects on 
testosterone indeed underlie these associations, the results presented in this thesis thus 
strongly suggest that the gene may act as a general regulator of the HP-axis function 
controlling hormone levels in humans, and further studies on how LIN28B contributes to 
hormonal regulation in vertebrates are therefore warranted. Overall, considering the vast 
potential of the HPG-axis to regulate human development, it however appears feasible that 
LIN28B‘s effects on some of the phenotypes might indeed be mediated through effects on 
this pathway. 
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6 Concluding remarks and future prospects 
The previous chapters have introduced the field of genetics of pubertal timing, summarized 
current knowledge about LIN28B and presented the results from the original studies serving 
as the foundation for this thesis project. During this thesis work, it has become evident that 
LIN28B is not only a pubertal timing gene, but rather a gene that contributes to the formation 
of multiple, seemingly unconnected traits across vertebrate species. With the studies 
presented in this thesis, we have shown that besides affecting pubertal timing LIN28B has 
pleiotropic effects on human body size, highlighted the potential significance of the gene’s 
actions for the function of the hypothalamic-pituitary axis, and contributed to the 
establishment of LIN28B genes as evolutionarily conserved regulators of vertebrate growth.  
In general, the results from our studies have been largely consistent with other studies 
assessing LIN28B function. For example the effects of LIN28B on body size appear particularly 
robust and replicable across vertebrates. Large GWAS studies now suggest that the genetic 
variants that decrease LIN28B expression lead to a proportional decrease in body size – an 
effect that we observed and report both in the human data and in our zebrafish models.  In 
addition, similarly to the data from Lin28B mice models, our zebrafish data indicates that 
this decrease in size is highly related to the actions of the gene during early development, 
namely embryogenesis and fetal development. These in turn appear to be closely related to 
changes in cellular metabolism. Importantly, our studies have also provided completely 
novel insight into LIN28B function. We have showed how the pubertal timing associated 
SNPs affect LIN28B expression primarily at the HP axis in adult humans, and suggested that 
in the same tissues LIN28B may contribute to gene expression dynamics also after the fetal 
stages. In addition, our studies show how LIN28B may directly affect serum testosterone 
levels in adult humans, which might be relevant in terms of understanding how the gene 
contributes to various phenotypes including pubertal timing. Altogether, these discoveries 
have opened up novel directions to explore the molecular mechanisms that regulate 
vertebrate growth later in life. For example, as LIN28Bs effects on growth appear robust and 
replicable in all the studied species, it would be tempting to study next whether the LIN28B-
related pathways might contribute also to variation in growth tempo and amplitude 
between species. 
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In addition to providing insight into LIN28B function, in the larger context this thesis has 
served as an example of studying the GWAS loci in general. Understanding the molecular 
background of the huge number of genetic associations that are currently available presents 
a big challenge. Even the question of whether it makes sense to try to make sense of all these 
associations with the current methods is valid, especially considering the relatively small 
proportion of trait variance an individual locus usually explains. Nevertheless, targeted 
studies may be warranted in particular if the genetic effect on the phenotype is large in the 
GWAS terms, and in case these have potential to reveal novel biological pathways behind 
the formation of complex traits – as was the case with LIN28B and pubertal timing in the 
beginning of this project.  
In the wake of this project, there are some key considerations that might be generalizable to 
other projects aiming study GWAS loci in detail.  First, studying gene expression may be a 
logical starting point for studying GWAS loci, as this may provide vital clues about the 
direction of the genetic effect and the causal tissues. Secondly, identification of the causal 
SNP in the region obviously may provide additional information about the molecular 
mechanisms, but is not absolutely necessary for further studies, particularly in case this 
would require considerable effort. Thirdly, understanding the “phenome-wide” 
consequences of a SNP on the other hand may offer vital cues about the function of a gene. 
In case one does not want to rely solely on published studies and does not have direct access 
to private cohort data, large scale biobanking initiatives like UK biobank now offer publicly 
available genetic association data on thousands of traits (19).  Finally, it appears that 
although in many cases the original associations may stem from relatively small differences 
in gene expression, “Mendelian” knockout/knock-in animal models may still be very useful 
in studying the molecular background of these associations. Despite the genetic lesion 
introduced in these models is usually more severe than the original variant causing the 
association (and in theory might lead to unexpected phenotypes), in many instances they 
still replicate the core features of the original association, like shown in this project. In fact, 
continuing to rely on the Mendelian models when studying the GWAS loci in animal models 
may be considered somewhat essential. The GWAS hits are based on studying large 
databases with thousands of human samples, and thus it would not be practical to try to 
mimic the observed effect size in animal models: to detect anything under such models 
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would likely require an impracticable/unethical amount of experiments and use of animals.  
Moreover, when considering which model organism to choose, it appears that it does not 
necessarily have to be closely related to humans, especially if there is reason to suspect that 
the association reflects an evolutionarily conserved genetic mechanism, like in the case of 
LIN28B. In general terms, however, perhaps the primary lesson that studying LIN28B has 
thought us is that there is a lot to be gained if it is possible to gather data from multiple 
sources, instead of just concentrating on studying a GWAS locus solely from one angle. 
Mostly, this has been made possible by public data sharing in the genetic community. In our 
project we have collected data from large population cohorts, gene expression databases 
and sequencing databases and combined this information with results from various different 
animal models including our own zebrafish models - simply to understand why certain 
genetic variants out of the millions of variants in our genome are linked to differences in 
pubertal timing in humans. By taking such a broad view, it is additionally easier to put the 
individual findings from this thesis into a bigger perspective: essentially this thesis project 
has not been dealing just with LIN28B expression levels and puberty in humans. Instead, we 
have been working to uncover mechanisms that regulate development, growth and disease 
and that may affect phenotypes, metabolism and ontogeny in a wide range of metazoans. 
Importantly, this thesis project can be seen also as a general example of the potential ways 
the GWAS findings can be followed up. 
Besides offering general guidelines into studying GWAS loci, the results from our project 
touch another timely topic in genetics. We are entering an era where human gene editing 
and “designer babies” have become reality. The experiences gained during this project 
underscore two central paradigms that all responsible researchers involved in genetic 
engineering should acknowledge. First, it is quite evident that the knowledge about the 
function of individual genes is still largely limited. For example, we started with LIN28B as a 
pubertal timing gene, but throughout this project, new associations with LIN28B and several 
human traits have constantly emerged. Secondly, following these associations, it is evident 
that LIN28B, like many genes, has pleiotropic effects on human phenotypes. It is thus naïve 
to think that by editing a single gene one would only affect a single trait. In the case of 
LIN28B, would one then prefer a version of the gene that increases height, intraocular 
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pressure and cancer risk, or the one that increases bone mineral density and risk for insomnia 
and depression? 
In the end, a logical, though slightly awkward question remains. This thesis was set to explore 
the molecular mechanisms behind the GWAS results - so do we now really know how LIN28B 
affects puberty?  And why might LIN28B, a stem cell factor controlling cell faith be related to 
all the other phenotypes that have been associated with the gene? Although we now 
certainly know more about LIN28B function than we did few years ago, many questions 
remain. For example, although LIN28B expression levels seem to correlate with vertebrate 
body size, potentially through effects on cellular metabolism and cell differentiation, the 
question - how does this actually happen – is still valid. On the other hand, we also recognize 
that LIN28B function at the HP axis and the gene’s contribution to regulation of hormone 
levels may be important for many of the phenotypes associated with the gene. Yet, whether 
this happens for example due to LIN28B affecting the somatic maturation and development 
of the HP axis, because it directly affects the expression of specific genes, or because it 
causes structural changes in the organization of these tissues remain unsolved: in theory all 
the above mechanisms could affect pubertal timing. Likewise, although we currently have 
evidence that LIN28B contributes to serum testosterone levels, which in theory might 
explain some of the GWAS findings, we still lack causal evidence for this as the mechanism 
behind the associations. Therefore, to protect oneself from the potential depressive 
consequences of being homozygous for the T allele of rs7759938 at the LIN28B region, I will 
leave these questions aside for a while. Instead, I will next concentrate on enjoying the fact 
that this thesis is now complete, and do my best to try to thank everybody who has been 
involved in this journey. 
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